Includes bibliographical references. ; Sponsored by the ASAIHL ; published_or_final_version ; Keynote address Wang, Gungwu Wang, Gungwu 2 ; Country reports ; A Health hazards of environmental pollution ; B Monitoring and instrumentation of environmental pollution ; C Legal controls of environmental pollution ; D Treatment and prevention of environmental pollution ; Australian approaches to finger printing sources of environmental lead with isotopes Gulson, B.L. Gulson, B.L. 13 ; The contribution of health care departments in tertiary institutions in Hong Kong to combating the hazards of pollution King, A.R. King, A.R. 19 ; The role of institutions of higher learning in combating health hazards of environmental pollution Rampal, K.G. Rampal, K.G. Ismail, N. Ismail, N. 26 ; Education programmes for training of agrichemical users in New Zealand Penman, D.R. Penman, D.R. 31 ; The role of Philippine ASAIHL institutions in combating the hazards of environmental pollution in Manila Quirino, T.U. Quirino, T.U. 35 ; Characteristics of acid rain in mainland China Hong, Y.T. Hong, Y.T. 42 ; Improving the total environmental of Singapore Tan, T.C. Tan, T.C. 46 ; The role of Thai universities in combating health hazards of environmental pollution Wangsuphachart, V.L. Wangsuphachart, V.L. 54 ; Introductino 63 ; Impact of industry on the health of surrounding communities: an analysis of epidemiological and public health challenges Bhopal, R.S. Bhopal, R.S. 65 ; Epidemiology and environmental health: reliable risk measurement in well-populations Lam, T.H. Lam, T.H. Hedley, A.J. Hedley, A.J. Peters, J. Peters, J. 74 ; An investigation into the presence of anaerobic bacteria in coastal waters of Hong Kong Boost, M.V. Boost, M.V. Wong, L.P. Wong, L.P. Wong, P.S. Wong, P.S. Ma, K.C. Ma, K.C. 82 ; Pollutions within the built environment Burnett, J. Burnett, J. Chan, D.W.T. Chan, D.W.T. 87 ; The effects of pesticides use on the health of on farmers in East Java, Indonesia Mukono, J. Mukono, J. 94 ; Noise and human activities in Hong Kong: a review Tan, T.C. Tan, T.C. Wong, L.T.L. Wong, L.T.L. 98 ; Analysis of organophosphorus insecticides in vegetables Tanner, P.A. Tanner, P.A. Leung, K.H. Leung, K.H. 105 ; Health risk and environmental pollution: the hidden factors Peters, J. Peters, J. Lui, J. Lui, J. Wong, C.M. Wong, C.M. Hedley, A.J. Hedley, A.J. Lam, T.H. Lam, T.H. Ong, S.G. Ong, S.G. Tam, A.Y.C. Tam, A.Y.C. 109 ; Risk assessment and management in the prevention of adverse effects on human health and the environment Spickett, J.T. Spickett, J.T. 117 ; Indoor and outdoor pollution in shops and offices in Hong Kong and health effects Bacon-Shone, J. Bacon-Shone, J. Liao, S. Liao, S. 122 ; Climatological assessment of potential heat stress in Hong Kong Kyle, W.J. Kyle, W.J. 126 ; Asbestos dust: a silent enemy Lam, K.Y. Lam, K.Y. 131 ; Integrating environmental health problems into urban planning: problems in the Asian-Pacific region and the challenges for universities Simpson, R.W. Simpson, R.W. 134 ; Organic solvent exposure in some manufacturing industries in Malaysia Tan, G.L.E. Tan, G.L.E. 138 ; Introduction 145 ; Monitoring and instrumentation of environmental pollution Tebbutt, T.H.Y. Tebbutt, T.H.Y. 145 ; The air quality monitoring programme of the Hong Kong environmental protection department Leung, R.T.M. Leung, R.T.M. 152 ; Low technology sampling can show spatial and temporal patterns of airborne metal pollution Lloyd, O.L. Lloyd, O.L. Fay, Gailey Fay, Gailey 159 ; Heavy metal contamination in coastal waters - a case study of the north coast of Central Java, Indonesia Supriharyono Supriharyono 165 ; Determination of phosphorus in natural water at parts per trillion level by laser thermal lens effect Wu, L. Wu, L. Siu, G.G. Siu, G.G. Chiu, D.D.S. Chiu, D.D.S. Stokes, M.J. Stokes, M.J. 171 ; A geographical approach to evaluating the human impact upon water quality Peart, M.R. Peart, M.R. 178 ; Modular auto-enrichment subsystem for use in environmental high pressure liquid chromatography analysis Chen, S.C. Chen, S.C. Chang, J.Y. Chang, J.Y. Wang, R.K. Wang, R.K. 183 ; Exposure to environmental pollutants in the work environment: a case study of a traffic toll booth in Malaysia Yaziz, M.I. Yaziz, M.I. 187 ; A proposed air quality index in Hong Kong Ng, C.N. Ng, C.N. Tanner, P.A. Tanner, P.A. 191 ; Background level of trace elements in soils of mainland China Chen, J.S. Chen, J.S. Tao, S. Tao, S. Deng, B.S. Deng, B.S. Wang, X.J. Wang, X.J. 196 ; Indoor monitoring of nitrogen oxides Cheung, M.T. Cheung, M.T. 200 ; Development of a piezoelectric crystal sorption detector for continuous monitoring of organic vapours at the workplace Fung, Y.S. Fung, Y.S. 205 ; Effects of some standard fixatives on fish gill morphology Shepherd, M. Shepherd, M. Ivanstoff, W. Ivanstoff, W. 210 ; Simulation of urban traffic noise on the environment Pamanikabud, P. Pamanikabud, P. 215 ; Investigation into the haze episodes in the Kelang Valley, Malaysia Samah, A.A. Samah, A.A. 221 ; Photoacoustic determination of organic pollutant gases in Hong Kong air Shi, B. Shi, B. Siu, G.G. Siu, G.G. Chiu, D.D.S. Chiu, D.D.S. 228 ; Application of the proton induced X-ray emission (PIXE) technique for the study of respirable suspended particulated (RSP) in Hong Kong Cai, Z.X. Cai, Z.X. Sze, P.Y.K. Sze, P.Y.K. Stokes, M.J. Stokes, M.J. Young, E.C.M. Young, E.C.M. 234 ; Follow-up stream sediment geochemical reconnaissance surveys in the vicinity of Tai Mo Shan, New Territories, Hong Kong Yim, W.W.S. Yim, W.W.S. Ng, C.Y. Ng, C.Y. Thornton, I. Thornton, I. 240 ; Introduction 249 ; Environmental pollution, higher education, and the rule of law Axline, M. Axline, M. 251 ; Legal controls of environmental pollution in Asia: how effective are they? Allen, J. Allen, J. 256 ; Hong Kong's water pollution controls: are we serious? Baillie, B.G. Baillie, B.G. 265 ; Environmental law in Hong Kong - a legal practitioner's point of view Skrine, R. Skrine, R. 277 ; Has the use of unleaded petrol provided a lead-free environment in Hong Kong? Au, C.T. Au, C.T. Chou, K.M. Chou, K.M. Wong, K.Y. Wong, K.Y. 282 ; The influence of the health act on present environmental problems Prabawa Utama, S.H. Prabawa Utama, S.H. 288 ; Environmental impact assessment and the role of legislation in environmental control - the case of Malaysia Idris, A.B. Idris, A.B. Fuad, A. Fuad, A. 294 ; Social responsbility awareness assessment of selected university respondents in combating environmental pollution Barcelona, A.C. Barcelona, A.C. 301 ; Alternatives to legal controls on environmental pollution Kaine, G. Kaine, G. Reeve, I. Reeve, I. Musgrave, W. Musgrave, W. 306 ; Introduction 315 ; Towards low-waste technology Diaper, J. Diaper, J. 317 ; Changing environmental values and institution building: the role of ASAIHL Hills, P. Hills, P. 325 ; Prevention and treatment of environmental pollution Mena, M.M. Mena, M.M. 332 ; The nature and control of motor vehicle emissions - methanol as an alternative fuel Cheung, C.S. Cheung, C.S. Lui, Y.B. Lui, Y.B. Leung, T.P. Leung, T.P. 335 ; Treatment and disposal of heavy metal wastes using cementitious solidification Peralta, G.L. Peralta, G.L. Ballesteros, F.C. Ballesteros, F.C. Cepeda, M.L. Cepeda, M.L. 340 ; A membrane anaerobic system for wastewater treatment Fakrul-Razi, A. Fakrul-Razi, A. 346 ; Prevention and treatment of air pollution in Hong Kong Lam, J.C. Lam, J.C. 351 ; Environmental education - a strategy for the treatment and prevention of environmental pollution Manalo, J.A. Manalo, J.A. Sergovia, V. Sergovia, V. Hocson, T.R. Hocson, T.R. 357 ; Bacterial reduction during sewage treatment - the Hong Kong experience Hodgkiss, I.J. Hodgkiss, I.J. Chiu, S.H.C. Chiu, S.H.C. 360 ; Treatment and prevention of environmental pollution in the Philippines De Jesus, E.M. De Jesus, E.M. 366 ; Microbiological study of shellfish and water quality in Deep Bay, Hong Kong Kueh, C.S.W. Kueh, C.S.W. 369 ; Environmental deterioration in greater Bangkok, Thailand Paraken, Y. Paraken, Y. 376 ; The 'polluter pays' principle: the distribution of economic impacts Rahim, K.A. Rahim, K.A. 378
A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10(-20)), ER-negative BC (P=1.1 × 10(-13)), BRCA1-associated BC (P=7.7 × 10(-16)) and triple negative BC (P-diff=2 × 10(-5)). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10(-3)) and ABHD8 (P<2 × 10(-3)). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3'-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk. ; We thank all the individuals who took part in these studies and all the researchers, clin- icians, technicians and administrative staff who have enabled this work to be carried out, in particular those involved in the COGS project: Rosalind A. Eeles, Ali Amin Al Olama, Zsofia Kote-Jarai, Sara Benlloch (PRACTICAL), Andrew Lee, and Ed Dicks, Craig Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, the staff of the CNIO genotyping unit, Daniel C. Tessier, Francois Bacot, Daniel Vincent, Sylvie LaBoissie ` re and Frederic Robidoux and the staff of the McGill University and Ge ́ nome Que ́ bec Innovation Centre, Sune F. Nielsen, Borge G. Nordestgaard, and the staff of the Copenhagen DNA laboratory, and Julie M. Cunningham, Sharon A. Windebank, Christopher A. Hilker, Jeffrey Meyer and the staff of Mayo Clinic Genotyping Core Facility. BCAC (acknowledgements by study) (ABCFS) : Maggie Angelakos, Judi Maskiell, Gillian Dite. (ABCS) C Ellen van der Schoot, Sanquin Amsterdam. (ACP) The ACP study wishes to thank the participants in the Thai Breast Cancer study. Special Thanks also go to the Thai Ministry of Public Health (MOPH), doctors and nurses who helped with the data collection process. Finally, the study would like to thank Dr Prat Boonyawongviroj, the former Permanent Secretary of MOPH and Dr Pornthep Siriwanarungsan, the Department Director-Generalof Disease Control who have supported the study throughout. (BBCS) Eileen Williams, Elaine Ryder-Mills, Kara Sargus (BIGGS) Niall McInerney, Gabrielle Colleran, Andrew Rowan, Angela Jones. (BSUCH) Peter Bugert, Medical Faculty Mannheim (CGPS) Staff and participants of the Copenhagen General Population Study. For the excellent technical assistance: Dorthe Uldall Andersen, Maria Birna Arnadottir, Anne Bank, Dorthe Kjeldgård Hansen (CNIO-BCS) Guillermo Pita, Charo Alonso, Daniel Herrero, Nuria A ́ lvarez, Pilar Zamora, Primitiva Menendez, the Human Genotyping-CEGEN Unit (CNIO)(CTS). The CTS Steering Committee includes Leslie Bernstein, Susan Neuhausen, James Lacey, Sophia Wang, Huiyan Ma, Yani Lu, and Jessica Clague DeHart at the Beckman Research Institute of City of Hope, Dennis Deapen, Rich Pinder, Eunjung Lee, and Fred Schumacher at the University of Southern California, Pam Horn-Ross, Peggy Reynolds, Christina Clarke Dur and David Nelson at the Cancer Prevention Institute of California, and Hoda Anton-Culver, Argyrios Ziogas, and Hannah Park at the University of California Irvine. (ESTHER) Hartwig Ziegler, Sonja Wolf, Volker Hermann. (GC-HBOC) Heide Hellebrand, Stefanie Engert and GC-HBOC (Supported by Deutsche Krebshilfe). (GENICA) The GENICA Network: Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and University of Tu ̈bingen, Germany [HB, Wing-Yee Lo, Christina Justenhoven], German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) [HB], Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany [Yon-Dschun Ko, Christian Baisch], Institute of Pathology, University of Bonn, Germany [Hans-Peter Fischer], Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany [UH], Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany [Thomas Bru ̈ning, Beate Pesch, Sylvia Rabstein, Anne Lotz]; and Institute of Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Germany [Volker Harth] (HEBCS) Kirsimari Aaltonen, Karl von Smitten, Sofia Khan, Tuomas Heikkinen, Irja Erkkila ̈ . (HMBCS) Natalia Antonenkova, Peter Hillemanns, Hans Christiansen and Johann H. Karstens (KBCP) Eija Myo ̈ ha ̈ nen, Helena Kemila ̈ inen. (kConFab/AOCS) We wish to thank Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (which has received funding from the NHMRC, the National Breast Cancer Foundation, Cancer Australia, and the National Institute of Health (USA)) for their contributions to this resource, and the many families who contribute to kConFab. (LAABC) We thank all the study participants and the entire data collection team, especially Annie Fung and June Yashiki. (LMBC) Gilian Peuteman, Dominiek Smeets, Thomas Van Brussel and Kathleen Corthouts. (MARIE) Petra Seibold, Judith Heinz, Nadia Obi, Alina Vrieling, Sabine Behrens, Ursula Eilber, Muhabbet Celik, Til Olchers and Stefan Nickels. (MCCS) MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry (VCR) and the Australian Institute of Health and Welfare (AIHW), including the National Death Index. (MBCSG) Bernard Peissel and Daniela Zaffaroni and Giulietta Scuvera of the Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy; Monica Barile and Irene Feroce of the Istituto Europeo di Oncologia (IEO), Milan, Italy; and the personnel of the Cogentech Cancer Genetic Test Laboratory. (MTLGEBCS) We would like to thank Martine Tranchant (CHU de Que ́ bec Research Center), Marie-France Valois, Annie Turgeon and Lea Heguy (McGill University Health Center, Royal Victoria Hospital; McGill Uni- versity) for DNA extraction, sample management and skilful technical assistance. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. (MYBRCA) Phuah Sze Yee, Peter Kang, Kang In Nee, Kavitta Sivanandan, Shivaani Mariapun, Yoon Sook-Yee, Daphne Lee, Teh Yew Ching and Nur Aishah Mohd Taib for DNA Extraction and patient recruitment. (NBHS) We thank study partcipants and research staff for their contributions and commitment to this study. (OBCS) Meeri Otsukka, Kari Mono- nen(OFBCR) Teresa Selander, Nayana Weerasooriya(ORIGO) We thank E. Krol-War- merdam, and J. Blom for patient accrual, administering questionnaires, and managing clinical information. The LUMC survival data were retrieved from the Leiden hospital- based cancer registry system (ONCDOC) with the help of Dr J. Molenaar. (PBCS) Louise Brinton, Mark Sherman, Neonila Szeszenia-Dabrowska, Beata Peplonska, Witold Zatonski, Pei Chao, Michael Stagner(pKARMA) The Swedish Medical Research Counsel. (RBCS) Petra Bos, Jannet Blom, Ellen Crepin, Elisabeth Huijskens, Annette Heemskerk, the Erasmus MC Family Cancer Clinic. (SASBAC) The Swedish Medical Research Counsel. (SBCGS) We thank study partcipants and research staff for their contributions and commitment to this study. (SBCS) Sue Higham, Helen Cramp, Ian Brock, Malcolm W. R. Reed, Sabapathy Balasubramanian and Dan Connley. (SEARCH) The SEARCH and EPIC teams. (SGBCC) We thank the participants and research coordinator Kimberley Chua. (SKKDKFZS) We thank all study participants, clinicians, family doctors, researchers and technicians for their contributions and commitment to this study. (TNBCC) Robert Pilarski and Charles Shapiro were instrumental in the formation of the OSU Breast Cancer Tissue Bank. We thank the Human Genetics Sample Bank for processing of samples and providing OSU Columbus area control samples. (UKBGS) We thank Breakthrough Breast Cancer and the Institute of Cancer Research for support and funding of the Breakthrough Generations Study, and the study participants, study staff, and the doctors, nurses and other health care providers and health information sources who have contributed to the study. We acknowledge NHS funding to the Royal Marsden/ ICR NIHR Biomedical Research Centre. OCAC (acknowledgements by study) : This study would not have been possible without the contributions of the following: J Dennis, P. Hall (COGS); D. C. Tessier, F. Bacot, D. Vincent, S. LaBoissie ` re and F. Robidoux and the staff of the genotyping unit, (Genome Quebec); D. C. Whiteman, P. M. Webb, A. C. Green, N. K. Hayward, P. G. Parsons, D. M. Purdie, B. M. Smithers, D. Gotley, A. Clouston, I. Brown, S. Moore. K. Harrap, T. Sadkowski, S. O'Brien, E. Minehan, D. Roffe, S. O'Keefe, S. Lipshut, G. Connor . Berry, F. Walker, T. Barnes, J. Thomas, L. Terry, M. Connard, L. Bowes, M-R. Malt, J. White, C. Mosse, N. Tait, C. Bambach, A. Biankan, R. Brancatisano, M. Coleman, M. Cox, S. Deane, G. L. Falk, J. Gallagher, M. Hollands, T. Hugh, D. Hunt, J. Jorgensen, C. Martin, M. Richardson, G. Smith, R. Smith, D. Storey, J. Avramovic, J. Croese, J. D'Arcy, S. Fairley, J. Hansen, J. Masson, L. Nathanson, B. O'Loughlin, L. Rutherford, R. Turner, M. Windsor, J. Bessell, P. Devitt, G. Jamieson, D. Watson, S. Blamey, A. Boussioutas, R. Cade, G. Crosthwaite, I. Faragher, J. Gribbin, G. Hebbard, G. Kiroff, B. Mann, R. Millar, P. O'Brien, R. Thomas, S. Wood, S. Archer, K. Faulkner, J. Hamdorf (ACS); R. Stuart-Harris, F. Kirsten, J. Rutovitz, P. Clingan, A.Glasgow, A. Proietto, S. Braye, G. Otton, J. Shannon, T. Bonaventura, J. Stewart, S. Begbie, M. Friedlander, D. Bell, S. Baron-Hay, G. Gard, D. Nevell, N. Pavlakis, S. Valmadre, B. Young, C Camaris, R. Crouch, L. Edwards, N. Hacker, D. Marsden, G. Robertson, P. Beale, J. Beith, J. Carter, C. Dalrymple, R. Houghton, P. Russell, L. Anderson, M. Links, J. Grygiel, J. Hill, A. Brand, K. Byth, R. Jaworski, P. Harnett, R. Sharma,.G Wain, D. Purdie, D. Whiteman, B. Ward, D. Papadimos, A. Crandon, M. Cummings, K. Horwood. A. Obermair, L. Perrin, D. Wyld, J. Nicklin, M. Davy, M. K. Oehler, C. Hall, T. Dodd, T. Healy, K. Pittman, D. Henderson, J. Miller, J. Pierdes, A. Achan, P. Blomfield, D. Challis, R. McIntosh, A. Parker, B. Brown, R. Rome, D. Allen, P. Grant, S. Hyde, R. Laurie, M. Robbie, D. Healy, T. Jobling, T. Manolitsas, J. McNealage, P Rogers, B. Susil, E. Sumithran, I. Simpson, I. Haviv, K. Phillips, D. Rischin, S. Fox, D. Johnson, S. Lade, P. Waring, M. Loughrey, N.O'Callaghan, B. Murray, L. Mileshkin, P. Allan; V. Billson, J. Pyman, D. Neesham, M. Quinn, A. Hamilton, C. Underhill, R. Bell, L. F Ng, R. Blum, V.Ganju, I. Hammond, C. Stewart, Y. Leung, M. Buck, N. Zeps (ACS); G. Peuteman, T. Van Brussel and D. Smeets (BEL); U. Eilber and T. Koehler (GER); L. Gacucova (HMO); P. Schu ̈rmann, F. Kramer, W. Zheng, T.-W. Park-Simon, K. Beer-Grondke and D. Schmidt (HJO); G.S. Keeney, S. Windebank, C. Hilker and J. Vollenweider (MAY); the state cancer registries of AL, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, and WYL (NHS); L. Paddock, M. King, U. Chandran, A. Samoila, and Y. Bensman (NJO); L. Brinton, M. Sherman, A. Hutchinson, N. Szeszenia- Dabrowska, B. Peplonska, W. Zatonski, A. Soni, P. Chao and M. Stagner (POL); ); C. Luccarini, P. Harrington the SEARCH team and ECRIC (SEA); the Scottish Gynaecological Clinical Trails group and SCOTROC1 investigators (SRO); W-H. Chow, Y-T. Gao (SWH); Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/ (TCGA); I. Jacobs, M. Widschwendter, E. Wozniak, N. Balogun, A. Ryan and J. Ford (UKO); Carole Pye (UKR); a full list of the investigators who contributed to the generation of the WTCCC data is available from http://www.wtccc.org.uk/ (WTCCC). CIMBA (acknowledgements by study) : (BCFR-AU) Maggie Angelakos, Judi Maskiell, Gillian Dite, Helen Tsimiklis. (BCFR-NY) We wish to thank members and participants in the New York site of the Breast Cancer Family Registry for their contributions to the study. (BCFR-ON) We wish to thank members and participants in the Ontario Familial Breast Cancer Registry for their contributions to the study. (BFBOCC-LT) We acknowledge Vilius Rudaitis, Laimonas Gris ˇ kevic ˇ ius, Ramu ̄ nas Janavic ˇ ius (if not in the authorship). BFBOCC-LV acknowledge Drs Janis Eglitis, Anna Krilova and Aivars Stengrevics. (BMBSA) We wish to thank the families who contribute to the BMBSA study. (BRICOH) We wish to thank Yuan Chun Ding and Linda Steele for their work in participant enrolment and biospecimen and data management.(CNIO) We thank Alicia Barroso, Rosario Alonso and Guillermo Pita for their assistance. (CONSIT TEAM) Alessandra Viel and Riccardo Dolcetti of the CRO Aviano National Cancer Institute, Aviano (PN), Italy; Laura Ottini of the 'Sapienza' University, Rome, Italy; Liliana Varesco of the IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy; Laura Papi and Gabriele Capone of the University of Florence, Florence, Italy; Antonella Savarese and Aline Martayan of the Istituto Nazionale Tumori Regina Elena, Rome, Italy; Stefania Tommasi and Brunella Pilato of the Istituto Nazionale Tumori 'Giovanni Paolo II', Bari, Italy. (CORE) The CIMBA data management and analysis is funded through Cancer Research- UK grant C12292/A11174. ACA is a Senior Cancer Research - UK Research Fellow. (EMBRACE) RE is supported by NIHR support to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. (FCCC) We thank Ms. JoEllen Weaver and Dr Betsy Bove for their technical support. (GEMO) Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) study: National Cancer Genetics Network ) UNICANCER Genetic Group * , France. We wish to thank all the GEMO collaborating groups for their contribution to this study. GEMO Collaborating Centres are: Coordinating Centres, Unite ́ Mixte de Ge ́ ne ́ tique Constitutionnelle des Cancers Fre ́ quents, Hospices Civils de Lyon - Centre Le ́ on Be ́ rard, and Equipe ) Ge ́ ne ́ tique du cancer du sein * , Centre de Recherche en Cance ́ rologie de Lyon: Olga Sinilnikova w , Sylvie Mazoyer, Francesca Damiola, Laure Barjhoux, Carole Verny-Pierre, Me ́ lanie Le ́ one, Nadia Boutry-Kryza, Alain Calender, Sophie Giraud; and Service de Ge ́ ne ́ tique Oncologique, Institut Curie, Paris: Dominique Stoppa-Lyonnet, Marion Gauthier-Villars, Bruno Buecher, Claude Houdayer, Etienne Rouleau, Lisa Golmard, Agne ` s Collet, Virginie Moncoutier, Ce ́ drick Lefol, Muriel Belotti, Antoine de Pauw, Camille Elan, Catherine Nogues, Emmanuelle Fourme, Anne-Marie Birot. Institut Gustave Roussy, Villejuif: Brigitte Bressac-de-Pail- lerets, Olivier Caron, Marine Guillaud-Bataille. Centre Jean Perrin, Clermont–Ferrand: Yves-Jean Bignon, Nancy Uhrhammer. Centre Le ́ on Be ́ rard, Lyon: Christine Lasset, Vale ́ rie Bonadona, Sandrine Handallou. Centre Franc ̧ ois Baclesse, Caen: Agne ` s Hardouin, Pascaline Berthet, Dominique Vaur, Laurent Castera. Institut Paoli Calmettes, Marseille: Hagay Sobol, Violaine Bourdon, Tetsuro Noguchi, Audrey Remenieras, Franc ̧ ois Eisinger. CHU Arnaud-de-Villeneuve, Montpellier: Isabelle Coupier, Pascal Pujol. Centre Oscar Lambret, Lille: Jean-Philippe Peyrat, Joe ̈ lle Fournier, Franc ̧ oise Re ́ villion, Philippe Vennin w , Claude Adenis. Centre Paul Strauss, Strasbourg: Danie ` le Muller, Jean-Pierre Fricker. Institut Bergonie ́ , Bordeaux: Emmanuelle Barouk-Simonet, Franc ̧ oise Bonnet, Virginie Bubien, Nicolas Sevenet, Michel Longy. Institut Claudius Regaud, Toulouse: Christine Toulas, Rosine Guimbaud, Laurence Gladieff, Viviane Feillel. CHU Grenoble: Dominique Leroux, He ́ le ` ne Dreyfus, Christine Rebischung, Magalie Peysselon. CHU Dijon: Fanny Coron, Laurence Faivre. CHU St-Etienne: Fabienne Prieur, Marine Lebrun, Caroline Kientz. Ho ˆ tel Dieu Centre Hospitalier, Chambe ́ ry: Sandra Fert Ferrer. Centre Antoine Lacassagne, Nice: Marc Fre ́ nay. CHU Limoges: Laurence Ve ́ nat-Bouvet. CHU Nantes: Capucine Delnatte. CHU Bretonneau, Tours: Isabelle Mortemousque. Groupe Hospitalier Pitie ́ -Salpe ́ trie ` re, Paris: Florence Coulet, Chrystelle Colas, Florent Soubrier, Mathilde Warcoin. CHU Vandoeuvre-les- Nancy: Johanna Sokolowska, Myriam Bronner. CHU Besanc ̧ on: Marie-Agne ` s Collonge- Rame, Alexandre Damette. Creighton University, Omaha, USA: Henry T. Lynch, Carrie L. Snyder. (G-FAST) We wish to thank the technical support of Ilse Coene en Brecht Crombez. (HCSC) We acknowledge Alicia Tosar for her technical assistance(HEBCS) HEBCS would like to thank Dr Kristiina Aittoma ̈ ki, Taru A. Muranen, Drs Carl Blomqvist and Kirsimari Aaltonen and RNs Irja Erkkila ̈ and Virpi Palola for their help with the HEBCS data and samples. (HEBON) The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) consists of the following Collaborating Centres: Coordinating center: Netherlands Cancer Institute, Amsterdam, NL: M.A. Rookus, F.B.L. Hogervorst, F.E. van Leeuwen, S. Verhoef, M.K. Schmidt, N.S. Russell, J.L. de Lange, R. Wijnands; Erasmus Medical Center, Rotterdam, NL: J.M. Colle ́ e, A.M.W. van den Ouweland, M.J. Hooning, C. Seynaeve, C.H.M. van Deurzen, I.M. Obdeijn; Leiden University Medical Center, NL: C.J. van Asperen, J.T. Wijnen, R.A.E.M. Tollenaar, P. Devilee, T.C.T.E.F. van Cronenburg; Radboud University Nijmegen Medical Center, NL: C.M. Kets, A.R. Mensenkamp; University Medical Center Utrecht, NL: M.G.E.M. Ausems, R.B. van der Luijt, C.C. van der Pol; Amsterdam Medical Center, NL: C.M. Aalfs, T.A.M. van Os; VU University Medical Center, Amsterdam, NL: J.J.P. Gille, Q. Waisfisz, H.E.J. Meijers-Heijboer; University Hospital Maastricht, NL: E.B. Go ́ mez- Garcia, M.J. Blok; University Medical Center Groningen, NL: J.C. Oosterwijk, A.H. van der Hout, M.J. Mourits, G.H. de Bock; The Netherlands Foundation for the detection of hereditary tumours, Leiden, NL: H.F. Vasen; The Netherlands Comprehensive Cancer Organization (IKNL): S. Siesling, J.Verloop; The Dutch Pathology Registry (PALGA): L.I.H. Overbeek. The HEBON study is supported by the Dutch Cancer Society grants NKI1998-1854, NKI2004-3088, NKI2007-3756, the Netherlands Organization of Scien- tific Research grant NWO 91109024, the Pink Ribbon grants 110005 and 2014- 187.WO76, the BBMRI grant NWO 184.021.007/CP46 and the Transcan grant JTC 2012 Cancer 12-054. HEBON thanks the registration teams of IKNL and PALGA for part of the data collection. (HRBCP) We wish to thank Hong Kong Sanatoriuma and Hospital for their continual support. (HUNBOCS) We wish to thank the Hungarian Breast and Ovarian Cancer Study Group members (Janos Papp, Tibor Vaszko, Aniko Bozsik, Timea Pocza, Judit Franko, Maria Balogh, Gabriella Domokos, Judit Ferenczi, Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary) and the clin- icians and patients for their contributions to this study.(HVH) We wish to thank the Oncogenetics Group (VHIO), and the High Risk and Cancer Prevention Unit of the University Hospital Vall d'Hebron.(ICO) We wish to thank the ICO Hereditary Cancer Program team led by Dr Gabriel Capella. (INHERIT) We would like to thank Dr Martine Dumont, Martine Tranchant for sample management and skilful technical assistance. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. J.S. and P.S. were part of the QC and Genotyping coordinating group of iCOGS (BCAC and CIMBA). (IPOBCS) We wish to thank Drs Ana Peixoto, Catarina Santos, Patrı ́ cia Rocha and Pedro Pinto for their skilful contribution to the study. (KCONFAB) We wish to thank Heather Thorne, Eveline Niedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics, and the Clinical Follow Up Study (which has received funding from the NHMRC, the National Breast Cancer Foundation, Cancer Australia, and the National Institute of Health (USA)) for their contributions to this resource, and the many families who contribute to kConFab. (MODSQUAD) Modifier Study of Quantitative Effects on Disease (MODSQUAD): we acknowledge ModSQuaD members Csilla Szabo (National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA); Lenka Foretova and Eva Machackova (Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno, Czech Republic); and Michal Zikan, Petr Pohlreich and Zdenek Kleibl (Oncogynecologic Center and Department of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic). (MSKCC) Anne Lincoln, Lauren Jacobs. (NICCC) We wish to thank the NICCC National Familial Cancer Consultation Service team led by Sara Dishon, the lab team led by Dr Flavio Lejbkowicz, and the research field operations team led by Dr Mila Pinchev. (NRG Oncology) We thank the investigators of the Australia New Zealand NRG Oncology group. (OCGN) We wish to thank members and participants in the Ontario Cancer Genetics Network for their contributions to the study. (OSU CCG) Leigha Senter, Kevin Sweet, Caroline Craven, and Michelle O'Conor were instrumental in accrual of study participants, ascertainment of medical records and database management. Samples were processed by the OSU Human Genetics Sample Bank. (SEABASS) We would like to thank Yip Cheng Har, Nur Aishah Mohd Taib, Phuah Sze Yee, Norhashimah Hassan and all the research nurses, research assistants and doctors involved in the MyBrCa Study for assistance in patient recruitment, data collection and sample preparation. In addition, we thank Philip Iau, Sng Jen-Hwei and Sharifah Nor Akmal for contributing samples from the Singapore Breast Cancer Study nd the HUKM-HKL Study respectively. The Malaysian Breast Cancer Genetic Study is funded by research grants from the Malaysian Ministry of Science, Technology and Innovation, Ministry of Higher Education (UM.C/HIR/MOHE/06) and charitable funding from Cancer Research Initiatives Foundation. (SMC) SMC team wishes to acknowledge the assistance of the Meirav Comprehensice breast cancer center team at the Sheba Medical Center for assistance in this study. (SWE-BRCA) Swedish scientists participating as SWE-BRCA collaborators are: from Lund University and University Hospital: Åke Borg, Håkan Olsson, Helena Jernstro ̈ m, Karin Henriksson, Katja Harbst, Maria Soller, Ulf Kristoffersson; from Gothenburg Sahlgrenska University Hospital: Anna O ̈ fverholm, Margareta Nordling, Per Karlsson, Zakaria Einbeigi; from Stockholm and Karolinska University Hospital: Anna von Wachenfeldt, Annelie Liljegren, Annika Lindblom, Brita Arver, Gisela Barbany Bustinza, Johanna Rantala; from Umeå University Hospital: Beatrice Melin, Christina Edwinsdotter Ardnor, Monica Emanuelsson; from Uppsala University: Hans Ehrencrona, Maritta Hellstro ̈ m Pigg, Richard Rosenquist; from Linko ̈ ping University Hospital: Marie Stenmark-Askmalm, Sigrun Lied- gren(UCHICAGO) We wish to thank Cecilia Zvocec, Qun Niu, physicians, genetic counsellors, research nurses and staff of the Cancer Risk Clinic for their contributions to this resource, and the many families who contribute to our programme. (UCLA) We thank Joyce Seldon MSGC and Lorna Kwan, MPH for assembling the data for this study. (UCSF) We would like to thank Dr Robert Nussbaum and the following genetic coun- sellors for participant recruitment: Beth Crawford, Kate Loranger, Julie Mak, Nicola Stewart, Robin Lee, Amie Blanco and Peggy Conrad. And thanks to Ms. Salina Chan for her data management. (UKFOCR) We thank Carole Pye, Patricia Harrington and Eva Wozniak for their contributions towards the UKFOCR. (VFCTG) Geoffrey Lindeman, Marion Harris, Martin Delatycki of the Victorian Familial Cancer Trials Group. We thank Sarah Sawyer and Rebecca Driessen for assembling this data and Ella Thompson for performing all DNA amplification. Grant Support : The COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175—HEALTH-F2-2009- 223175). BCAC is funded by Cancer Research UK [C1287/A10118, C1287/A12014] and by the European Community ́ s Seventh Framework Programme under grant agreement number 223175 (grant number HEALTH-F2-2009-223175) (COGS). The CIMBA data management and analytical work is funded by Cancer Research UK (C12292/A11174, C12292/A20861). Funding for the iCOGS infrastructure came from: the European Community's Seventh Framework Programme under grant agreement n ° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund. The Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). The scientific development and funding for this project were in part supported by the US National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112). This study made use of data generated by the Wellcome Trust Case Control consortium. Funding for the project was provided by the Wellcome Trust under award 076113. The results published here are in part based on data generated by The Cancer Genome Atlas Project established by the National Cancer Institute and National Human Genome Research Institute. Personal support: K.L. is supported by a K99/R00 grant from the National Cancer Institute (Grant number 1K99CA184415-01). This project was supported in part by a Program Project Development Grant from the Ovarian Cancer Research Fund (S.A.G and A.M). The in vitro aspects of this project were performed within the Norris Cancer Centre at USC, which is supported in part by award number P30CA014089 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. D.F.E. is a Principal Research Fellow of Cancer Research UK. A.C.A. is a Cancer Research—UK Senior Cancer Research Fellow. G.C.-T. and P.M.W. are supported by the National Health and Medical Research Council. (WCP) B.Y.K is funded by the American Cancer Society Early Detection Professorship (SIOP- 06-258-01-COUN) and the National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000124. L.E.K. is supported by a Canadian Institutes of Health Research Investigator award (MSH-87734). S.P.K. is supported by a Gates Cambridge Scholarship. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. RB was a Cancer Institute NSW Clinical Research Fellow. M.C.S. is a NHMRC Senior Research Fellow. A.K.G. was funded by 5U01CA113916, R01CA140323, and by the Chancellors Distinguished Chair in Biomedical Sciences Professorship. J.L.H. is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow. S.L.E. and J.D.F. are supported by Fellowships from the National Breast Cancer Foundation (NBCF) Australia and NHMRC project grant (1058415). Funding : BCAC: The Australian Breast Cancer Family Study (ABCFS) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. The ABCS study was supported by the Dutch Cancer Society [grants NKI 2007-3839; 2009 4363]. The ACP study is funded by the Breast Cancer Research Trust, UK. The BBCS is funded by Cancer Research UK and Breakthrough Breast Cancer and acknowledges NHS funding to the NIHR Biomedical Research Centre, and the National Cancer Research Network (NCRN).ES is supported by NIHR Comprehensive Biomedical Research Centre, Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London, United Kingdom. IT is supported by the Oxford Biomedical Research Centre.The BSUCH study was supported by the Dietmar-Hopp Foundation, the Helmholtz Society and the German Cancer Research Center (DKFZ). The CGPS was supported by the Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council and Herlev HospitalThe CNIO-BCS was supported by the Instituto de Salud Carlos III, the Red Tema ́ tica de Investigacio ́ n Cooperativa en Ca ́ ncer and grants from the Asociacio ́ n Espan ̃ ola Contra el Ca ́ ncer and the Fondo de Investigacio ́ n Sanitario (PI11/00923 and PI12/00070). The CTS was initially supported by the California Breast Cancer Act of 1993 and the California Breast Cancer Research Fund (contract 97-10500) and is cur- rently funded through the National Institutes of Health (R01 CA77398). Collection of cancer incidence data was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. HAC receives support from the Lon V Smith Foundation (LVS39420). The ESTHER study was supported by a grant from the Baden Wu ̈rttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe). The GC-HBOC was supported by Deutsche Krebshilfe (107 352). The GENICA was funded by the Federal Ministry of Education and Research (BMBF) Germany grants 01KW9975/5, 01KW9976/8, 01KW9977/0 and 01KW0114, the Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany. The HEBCS was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society, The Nordic Cancer Union and the Sigrid Juselius Foundation. The HMBCS was supported by a grant from the Friends of Hannover Medical School and by the Rudolf Bartling Foundation. The KBCP was financially supported by the special Government Funding (EVO) of Kuopio University Hospital grants, Cancer Fund of North Savo, the Finnish Cancer Organizations, and by the strategic funding of the University of Eastern Finland. kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia, The Cancer Foundation of Western Australia, Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; 400413, 400281, 199600). LAABC is supported by grants (1RB-0287, 3PB-0102, 5PB-0018, 10PB-0098) from the California Breast Cancer Research Program. Incident breast cancer cases were collected by the USC Cancer Surveillance Program (CSP), which is supported under subcontract by the California Department of Health. The CSP is also part of the National Cancer Institute's Division of Cancer Prevention and Control Surveillance, Epidemiology, and End Results Program, under contract number N01CN25403. LMBC is supported by the 'Stichting tegen Kanker' (232-2008 and 196-2010). Diether Lambrechts is supported by the FWO and the KULPFV/10/016-SymBioSysII.The MARIE study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I, 106332, 108253, 108419], the Hamburg Cancer Society, the German Cancer Research Center (DKFZ) and the Federal Ministry of Education and Research (BMBF) Germany [01KH0402]. (MBCSG) is supported by grants from the Italian Association for Cancer Research (AIRC) and by funds from the Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000'). The work of MTLGEBCS was supported by the Quebec Breast Cancer Foundation, the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program – grant # CRN-87521 and the Ministry of Economic Development, Innovation and Export Trade – grant # PSR-SIIRI-701.MYBRCA is funded by research grants from the Malaysian Ministry of Science, Technology and Innovation (MOSTI), Malaysian Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation (CARIF). Additional controls were recruited by the Singapore Eye Research Institute, which was supported by a grant from the Biomedical Research Council (BMRC08/1/35/19/550), Singapore and the National medical Research Council, Singa- pore (NMRC/CG/SERI/2010). The NBHS was supported by NIH grant R01CA100374. Biological sample preparation was conducted the Survey and Biospecimen Shared Resource, which is supported by P30 CA68485. The OBCS was supported by research grants from the Finnish Cancer Foundation, the Academy of Finland (grant number 250083, 122715 and Center of Excellence grant number 251314), the Finnish Cancer Foundation, the Sigrid Juselius Foundation, the University of Oulu, the University of Oulu Support Foundation and the special Governmental EVO funds for Oulu University Hospital-based research activities. The Ontario Familial Breast Cancer Registry (OFBCR) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ORIGO study was supported by the Dutch Cancer Society (RUL 1997-1505) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL CP16). The PBCS was funded by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The pKARMA study was supported by Ma ̈ rit and Hans Rausings Initiative Against Breast CancerThe RBCS was funded by the Dutch Cancer Society (DDHK 2004-3124, DDHK 2009-4318). The SASBAC study was sup- ported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. The SBCGS was supported primarily by NIH grants R01CA64277, R01CA148667, and R37CA70867. Biological sample preparation was conducted the Survey and Biospecimen Shared Resource, which is supported by P30 CA68485. The scientific development and funding of this project were, in part, supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON) Network U19 CA148065.The SBCS was supported by Yorkshire Cancer Research S295, S299, S305PA and Sheffield Experimental Cancer Medicine Centre.SEARCH is funded by a programme grant from Cancer Research UK [C490/A10124] and supported by the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge.SGBCC is funded by the NUS start-up Grant, National University Cancer Institute Singapore (NCIS) Centre Grant and the NMRC Clinician Scientist Award. Additional controls were recruited by the Singapore Consortium of Cohort Studies-Multi-ethnic cohort (SCCS-MEC), which was funded by the Biomedical Research Council, grant number: 05/ 1/21/19/425.SKKDKFZS is supported by the DKFZ. The TNBCC was supported by: a Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a grant from the Breast Cancer Research Foundation, a generous gift from the David F. and Margaret T. Grohne Family Foundation, the Hellenic Cooperative Oncology Group research grant (HR R_BG/04) and the Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II, the European Union (European Social Fund – ESF), and Greek national funds through the Operational Program 'Education and Lifelong Learning' of the National Strategic Reference Framework (NSRF) - ARISTEIA. The UKBGS is funded by Breakthrough Breast Cancer and the Institute of Cancer Research (ICR), London. ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. Funding : OCAC : Funding of the constituent studies was provided by the American Cancer Society (CRTG-00-196-01-CCE); the California Cancer Research Program (00-01389 V-20170, N01-CN25403, 2II0200); the Canadian Institutes for Health Research (MOP-86727); Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124, C536/A13086, C536/A6689); the Celma Mastry Ovarian Cancer Foundation; the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; Imperial Experimental Cancer Research Centre (C1312/A15589); the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L and S Milken Foun- dation; the Polish Ministry of Science and Higher Education (4 PO5C 028 14, 2 PO5A 068 27); Malaysian Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation; the Roswell Park Cancer Institute Alliance Foundation; the US National Cancer Institute (K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50- CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01- CA058598, R01-CA058860, R01-CA061107, R01-CA061132, R01-CA063682, R01-CA064277, R01-CA067262, R01- CA071766, R01-CA074850, R01-CA076016, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01- CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA114343, R01-CA126841, R01- CA136924, R01-CA149429, R03-CA113148, R03-CA115195, R37-CA070867, R37-CA70867, U01-CA069417, U01- CA071966, R01-CA063678 and Intramural research funds); the US Army Medical Research and Material Command (DAMD17-98-1- 8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1- 0669, W81XWH-10-1-0280); the National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01 GB 9401); the state of Baden-Wu ̈rttemberg through Medical Faculty of the University of Ulm (P.685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V. Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital 'Womens Health Theme' and the Royal Marsden Hospital; WorkSafeBC. Funding : CIMBA (BCFR—all) : This work was supported by grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centres in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. (BFBOCC-LT) BFBOCC is partly supported by: Lithuania (BFBOCC-LT): Research Council of Lithuania grant LIG-07/2012; (BIDMC) BIDMC is supported by the Breast Cancer Research Foundation. (BMBSA) BRCA-gene mutations and breast cancer in South African women (BMBSA) was supported by grants from the Cancer Association of South Africa (CANSA) to Elizabeth J. van Rensburg. (BRICOH) SLN was partially supported by the Morris and Horowitz Familes Endowed Professorship. (CBCS) This work was supported by the NEYE Foundation. (CNIO) This work was partially supported by Spanish Association against Cancer (AECC08), RTICC 06/0020/1060, FISPI08/1120, Mutua Madrilen ̃ a Foundation (FMMA) and SAF2010-20493 (COH-CCGCRN) City of Hope Clinical Cancer Genetics Community Network and the Hereditary Cancer Research Registry, supported in part by Award Number RC4CA153828 (PI: J. Weitzel) from the National Cancer Institute and the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. (CONSIT TEAM) Funds from Italian citizens who allocated the 5x1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects '5x1000') to Siranoush Manoukian. (CORE) The CIMBA data management and data analysis were supported by Cancer Research – UK grants C12292/A11174 and C1287/A10118.SH is supported by an NHMRC Program Grant to GCT. ACA is a Cancer Research -UK Senior Cancer Research Fellow. (DEMOKRITOS) This research has been co-financed by the European Union (European Social Fund – ESF) and Greek national funds through the Operational Program 'Education and Lifelong Learning' of the National Strategic Reference Frame- work (NSRF) - Research Funding Program of the General Secretariat for Research and Technology: ARISTEIA. Investing in knowledge society through the European Social Fund.(DKFZ) The DKFZ study was supported by the DKFZ. (EMBRACE) EMBRACE is supported by Cancer Research UK Grants C1287/A10118 and C1287/A11990. D. Gareth Evans and Fiona Lalloo are supported by an NIHR grant to the Biomedical Research Centre, Manchester. The Investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. (FCCC) The authors acknowledge support from The University of Kansas Cancer Center (P30 CA168524) and the Kansas Bioscience Authority Eminent Scholar Program. (GC-HBOC) The German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC) is supported by the German Cancer Aid (grant no 109076, Rita K. Schmutzler) and by the Center for Molecular Medicine Cologne (CMMC). (GEMO) The study was supported by the Ligue Nationale Contre le Cancer; the Association 'Le cancer du sein, parlons-en!' Award; the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program and the French National Institute of Cancer (INCa). (GEORGETOWN) CI received support from the Non-Therapeutic Subject Registry Shared Resource at Georgetown University (NIH/NCI grant P30-CA051008), the Fisher Center for Familial Cancer Research, and Swing Fore the Cure. (G-FAST) Kim De Leeneer is supported by GOA grant BOF10/ GOA/019 (Ghent University) and spearhead financing of Ghent University Hospital. (HCSC) HCSC supported by a grant RD12/0036/0006 and 12/00539 from ISCIII (Spain), partially supported by European Regional Development FEDER funds. (HEBCS) The HEBCS was financially supported by the Helsinki University Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society and the Sigrid Juselius Foundation. (HEBON) The HEBON study is supported by the Dutch Cancer Society grants NKI1998-1854, NKI2004-3088, NKI2007-3756, the Netherlands Organization of Scientific Research grant NWO 91109024, the Pink Ribbon grant 110005 and the BBMRI grant NWO 184.021.007/CP46. HEBON thanks the registration teams of the Comprehensive Cancer Centre Netherlands and Comprehensive Centre South (together the Netherlands Cancer Registry) and PALGA (Dutch Pathology Registry) for part of the data collection. (HRBCP) HRBCP is supported by The Hong Kong Hereditary Breast Cancer Family Registry and the Dr Ellen Li Charitable Foundation, Hong Kong (HUNBOCS) Hungarian Breast and Ovarian Cancer Study was supported by Hungarian Research Grants KTIA-OTKA CK-80745, OTKA K-112228 and the Norwegian EEA Financial Mechanism Hu0115/NA/2008-3/OP-9. (ICO) Contract grant sponsor: Asociacio ́ n Espan ̃ ola Contra el Ca ́ ncer, Spanish Health Research Fund; Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. Contract grant numbers: ISCIIIRETIC RD06/0020/1051, RD12/0036/008, PI10/01422, PI10/ 00748, PI13/00285, PIE13/00022, 2009SGR290 and 2014SGR364. (IHCC) The IHCC was supported by Grant PBZ_KBN_122/P05/2004(ILUH) The ILUH group was supported by the Icelandic Association 'Walking for Breast Cancer Research' and by the Landspitali University Hospital Research Fund. (INHERIT) This work was supported by the Canadian Institutes of Health Research for the 'CIHR Team in Familial Risks of Breast Cancer' program, the Canadian Breast Cancer Research Alliance-grant #019511 and the Ministry of Economic Development, Innovation and Export Trade – grant # PSR-SIIRI- 701. (IOVHBOCS) IOVHBOCS is supported by Ministero della Salute and '5 1,000' Istituto Oncologico Veneto grant. (IPOBCS) This study was in part supported by Liga Portuguesa Contra o Cancro.(KCONFAB) kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia; (KOHBRA) KOHBRA is supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs,Republic of Korea (1020350). (MAYO) MAYO is supported by NIH grants CA116167, CA128978 and CA176785, an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), a U.S. Department of Defence Ovarian Cancer Idea award (W81XWH-10-1-0341), a grant from the Breast Cancer Research Foundation, a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. (MCGILL) Jewish General Hospital Weekend to End Breast Cancer, Quebec Ministry of Economic Development, Innovation and Export Trade (MODSQUAD) MODSQUAD was supported by MH CZ - DRO (MMCI, 00209805) and by the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101) to LF, and by Charles University in Prague project UNCE204024 (MZ). (MSKCC) MSKCC is supported by grants from the Breast Cancer Research Foundation, the Robert and Kate Niehaus Clinical Cancer Genetics Initiative, and the Andrew Sabin Research Fund. (NAROD) 1R01 CA149429- 01. (NCI) The research of Drs MH Greene, JT Loud and PL Mai was supported by the Intramural Research Program of the US National Cancer Institute, NIH, and by support services contracts NO2-CP-11019-50 and N02-CP-65504 with Westat, Inc, Rockville, MD. (NICCC) NICCC is supported by Clalit Health Services in Israel. Some of it's activities are supported by the Israel Cancer Association and the Breast Cancer Research Foundation (BCRF), NY. (NNPIO) This work has been supported by the Russian Federation for Basic Research (grants 13-04-92613, 14-04-93959 and 15-04-01744). (NRG Oncology) This study was supported by National Cancer Institute grants to the NRG Oncology Administrative Office and Tissue Bank (CA 27469), the NRG Oncology Statistical and Data Center (CA 37517), and NRG Oncology's Cancer Prevention and Control Committee (CA 101165). (OSU CCG) OSUCCG is supported by the Ohio State University Comprehensive Cancer Center. (PBCS) This work was supported by the ITT (Istituto Toscano Tumori) grants 2011-2013. (SEABASS) Ministry of Science, Technol- ogy and Innovation, Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation. (SMC) This project was partially funded through a grant by the Isreal cancer association and the funding for the Israeli Inherited breast cancer consortium (SWE-BRCA) SWE-BRCA collaborators are supported by the Swedish Cancer Society. (UCHICAGO) UCHICAGO is supported by NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA125183), R01 CA142996, 1U01CA161032 and by the Ralph and Marion Falk Medical Research Trust, the Entertainment Industry Fund National Women's Cancer Research Alliance and the Breast Cancer research Foundation. OIO is an ACS Clinical Research Professor.(UCLA) Jonsson Comprehensive Cancer Center Foundation; Breast Cancer Research Foundation. (UCSF) UCSF Cancer Risk Program and Helen Diller Family Comprehensive Cancer Center. (UKFOCR) UKFOCR was supported by a project grant from CRUK to Paul Pharoah. (UPENN) National Institutes of Health (NIH) (R01-CA102776 and R01- CA083855; Breast Cancer Research Foundation; Susan G. Komen Foundation for the cure, Basser Research Center for BRCA. (UPITT/MWH) Frieda G. and Saul F. Shapira BRCA-Associated Cancer Research Program;Hackers for Hope Pittsburgh. (VFCTG) Victorian Cancer Agency, Cancer Australia, National Breast Cancer Foundation unding for the iCOGS infrastructure came from: the European Community's Seventh Framework Programme under grant agreement n ° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/ A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund and grants R01-CA122443 and P50-CA136393. ; Sí
COVID-STORM Clinicians Giuseppe Foti1, Giacomo Bellani 1, Giuseppe Citerio1, Ernesto Contro1, Alberto Pesci2, Maria Grazia Valsecchi3, Marina Cazzaniga4 1Department of Emergency, Anesthesia and Intensive Care, School of Medicine and Surgery, University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy. 2Department of Pneumology, School of Medicine and Surgery, University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy. 3Center of Bioinformatics and Biostatistics, School of Medicine and Surgery, University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy. 4Phase I Research Center, School of Medicine and Surgery, University of Milano-Bicocca, San Gerardo Hospital, Monza IT ; COVID Clinicians Jorge Abad1, Sergio Aguilera-Albesa2, Ozge Metin Akcan3, Ilad Alavi Darazam4, Juan C. Aldave5, Miquel Alfonso Ramos6, Seyed Alireza Nadji7, Gulsum Alkan8, Jerome Allardet-Servent9, Luis M. Allende10, Laia Alsina11, Marie-Alexandra Alyanakian12, Blanca Amador-Borrero13, Zahir Amoura14, Arnau Antolí15, Sevket Arslan16, Sophie Assant17, Terese Auguet18, Axelle Azot19, Fanny Bajolle20, Aurélie Baldolli21, Maite Ballester22, Hagit Baris Feldman23, Benoit Barrou24, Alexandra Beurton25, Agurtzane Bilbao26, Geraldine Blanchard-Rohner27, Ignacio Blanco1, Adeline Blandinières28, Daniel Blazquez-Gamero29, Marketa Bloomfield30, Mireia Bolivar-Prados31, Raphael Borie32, Cédric Bosteels33, Ahmed A. Bousfiha34, Claire Bouvattier35, Oksana Boyarchuk36, Maria Rita P. Bueno37, Jacinta Bustamante20, Juan José Cáceres Agra38, Semra Calimli39, Ruggero Capra40, Maria Carrabba41, Carlos Casasnovas42, Marion Caseris43, Martin Castelle44, Francesco Castelli45, Martín Castillo de Vera46, Mateus V. Castro37, Emilie Catherinot47, Martin Chalumeau48, Bruno Charbit49, Matthew P. Cheng50, Père Clavé31, Bonaventura Clotet51, Anna Codina52, Fatih Colkesen53, Fatma Çölkesen54, Roger Colobran55, Cloé Comarmond56, David Dalmau57, David Ross Darley58, Nicolas Dauby59, Stéphane Dauger60, Loic de Pontual61, Amin Dehban62, Geoffroy Delplancq63, Alexandre Demoule64, Jean-Luc Diehl65, Stephanie Dobbelaere66, Sophie Durand67, Waleed Eldars68, Mohamed Elgamal69, Marwa H. Elnagdy70, Melike Emiroglu71, Emine Hafize Erdeniz72, Selma Erol Aytekin73, Romain Euvrard74, Recep Evcen75, Giovanna Fabio41, Laurence Faivre76, Antonin Falck43, Muriel Fartoukh77, Morgane Faure78, Miguel Fernandez Arquero79, Carlos Flores80, Bruno Francois81, Victoria Fumadó82, Francesca Fusco83, Blanca Garcia Solis84, Pascale Gaussem85, Juana Gil-Herrera86, Laurent Gilardin87, Monica Girona Alarcon88, Mònica Girona-Alarcón88, Jean-Christophe Goffard89, Funda Gok90, Rafaela González-Montelongo91, Antoine Guerder92, Yahya Gul93, Sukru Nail Guner93, Marta Gut94, Jérôme Hadjadj95, Filomeen Haerynck96, Rabih Halwani97, Lennart Hammarström98, Nevin Hatipoglu99, Elisa Hernandez-Brito100, Cathérine Heijmans101, María Soledad Holanda-Peña102, Juan Pablo Horcajada103, Levi Hoste104, Eric Hoste105, Sami Hraiech106, Linda Humbert107, Alejandro D. Iglesias108, Antonio Íñigo-Campos91, Matthieu Jamme109, María Jesús Arranz110, Iolanda Jordan111, Philippe Jorens112, Fikret Kanat113, Hasan Kapakli114, Iskender Kara115, Adem Karbuz116, Kadriye Kart Yasar117, Sevgi Keles118, Yasemin Kendir Demirkol119, Adam Klocperk120, Zbigniew J. Król121, Paul Kuentz122, Yat Wah M. Kwan123, Jean-Christophe Lagier124, Bart N. Lambrecht33, Yu-Lung Lau125, Fleur Le Bourgeois60, Yee-Sin Leo126, Rafael Leon Lopez127, Daniel Leung125, Michael Levin128, Michael Levy60, Romain Lévy20, Zhi Li49, Agnes Linglart129, Bart Loeys130, José M. Lorenzo-Salazar91, Céline Louapre131, Catherine Lubetzki131, Charles-Edouard Luyt132, David C. Lye133, Davood Mansouri134, Majid Marjani135, Jesus Marquez Pereira136, Andrea Martin137, David Martínez Pueyo138, Javier Martinez-Picado139, Iciar Marzana140, Alexis Mathian14, Larissa R. B. Matos37, Gail V. Matthews141, Julien Mayaux142, Jean-Louis Mège143, Isabelle Melki144, Jean-François Meritet145, Ozge Metin146, Isabelle Meyts147, Mehdi Mezidi148, Isabelle Migeotte149, Maude Millereux150, Tristan Mirault151, Clotilde Mircher67, Mehdi Mirsaeidi152, Abián Montesdeoca Melián153, Antonio Morales Martinez154, Pierre Morange155, Clémence Mordacq107, Guillaume Morelle156, Stéphane Mouly13, Adrián Muñoz-Barrera91, Leslie Naesens157, Cyril Nafati158, João Farela Neves159, Lisa FP. Ng160, Yeray Novoa Medina161, Esmeralda Nuñez Cuadros162, J. Gonzalo Ocejo-Vinyals163, Zerrin Orbak164, Mehdi Oualha20, Tayfun Özçelik165, Qiang Pan-Hammarström166, Christophe Parizot142, Tiffany Pascreau167, Estela Paz-Artal168, Sandra Pellegrini49, Rebeca Pérez de Diego84, Aurélien Philippe169, Quentin Philippot77, Laura Planas-Serra170, Dominique Ploin171, Julien Poissy172, Géraldine Poncelet43, Marie Pouletty173, Paul Quentric142, Didier Raoult143, Anne-Sophie Rebillat67, Ismail Reisli174, Pilar Ricart175, Jean-Christophe Richard176, Nadia Rivet28, Jacques G. Rivière177, Gemma Rocamora Blanch15, Carlos Rodrigo1, Carlos Rodriguez-Gallego178, Agustí Rodríguez-Palmero179, Carolina Soledad Romero180, Anya Rothenbuhler181, Flore Rozenberg182, Maria Yolanda Ruiz del Prado183, Joan Sabater Riera15, Oliver Sanchez184, Silvia Sánchez-Ramón185, Agatha Schluter170, Matthieu Schmidt186, Cyril E. Schweitzer187, Francesco Scolari188, Anna Sediva189, Luis M. Seijo190, Damien Sene13, Sevtap Senoglu117, Mikko R. J. Seppänen191, Alex Serra Ilovich192, Mohammad Shahrooei62, Hans Slabbynck193, David M. Smadja194, Ali Sobh195, Xavier Solanich Moreno15, Jordi Solé-Violán196, Catherine Soler197, Pere Soler-Palacín137, Yuri Stepanovskiy198, Annabelle Stoclin199, Fabio Taccone149, Yacine Tandjaoui-Lambiotte200, Jean-Luc Taupin201, Simon J. Tavernier202, Benjamin Terrier203, Caroline Thumerelle107, Gabriele Tomasoni204, Julie Toubiana48, Josep Trenado Alvarez205, Sophie Trouillet-Assant206, Jesús Troya207, Alessandra Tucci208, Matilde Valeria Ursini83, Yurdagul Uzunhan209, Pierre Vabres210, Juan Valencia-Ramos211, Eva Van Braeckel33, Stijn Van de Velde212, Ana Maria Van Den Rym84, Jens Van Praet213, Isabelle Vandernoot214, Hulya Vatansev215, Valentina Vélez-Santamaria42, Sébastien Viel171, Cédric Vilain216, Marie E. Vilaire67, Audrey Vincent35, Guillaume Voiriot217, Fanny Vuotto107, Alper Yosunkaya90, Barnaby E. Young126, Fatih Yucel218, Faiez Zannad219, Mayana Zatz37, Alexandre Belot220* ; Imagine COVID Group Christine Bole-Feysot, Stanislas Lyonnet*, Cécile Masson, Patrick Nitschke, Aurore Pouliet, Yoann Schmitt, Frederic Tores, Mohammed Zarhrate Imagine Institute, Université de Paris, INSERM UMR 1163, Paris, France. *Leader of the Imagine COVID Group. ; French COVID Cohort Study Group Laurent Abel1, Claire Andrejak2, François Angoulvant3, Delphine Bachelet4, Romain Basmaci5, Sylvie Behillil6, Marine Beluze7, Dehbia Benkerrou8, Krishna Bhavsar4, François Bompart9, Lila Bouadma4, Maude Bouscambert10, Mireille Caralp11, Minerva Cervantes-Gonzalez12, Anissa Chair4, Alexandra Coelho13, Camille Couffignal4, Sandrine Couffin-Cadiergues14, Eric D'Ortenzio12, Charlene Da Silveira4, Marie-Pierre Debray4, Dominique Deplanque15, Diane Descamps16, Mathilde Desvallées17, Alpha Diallo18, Alphonsine Diouf13, Céline Dorival8, François Dubos19, Xavier Duval4, Philippine Eloy4, Vincent VE Enouf20, Hélène Esperou21, Marina Esposito-Farese4, Manuel Etienne22, Nadia Ettalhaoui4, Nathalie Gault4, Alexandre Gaymard10, Jade Ghosn4, Tristan Gigante23, Isabelle Gorenne4, Jérémie Guedj24, Alexandre Hoctin13, Isabelle Hoffmann4, Salma Jaafoura21, Ouifiya Kafif4, Florentia Kaguelidou25, Sabina Kali4, Antoine Khalil4, Coralie Khan17, Cédric Laouénan4, Samira Laribi4, Minh Le4, Quentin Le Hingrat4, Soizic Le Mestre18, Hervé Le Nagard24, François-Xavier Lescure4, Yves Lévy26, Claire Levy-Marchal27, Bruno Lina10, Guillaume Lingas24, Jean Christophe Lucet4, Denis Malvy28, Marina Mambert13, France Mentré4, Noémie Mercier18, Amina Meziane8, Hugo Mouquet20, Jimmy Mullaert4, Nadège Neant24, Marion Noret29, Justine Pages30, Aurélie Papadopoulos21, Christelle Paul18, Nathan Peiffer-Smadja4, Ventzislava Petrov-Sanchez18, Gilles Peytavin4, Olivier Picone31, Oriane Puéchal12, Manuel Rosa-Calatrava10, Bénédicte Rossignol23, Patrick Rossignol32, Carine Roy4, Marion Schneider4, Caroline Semaille12, Nassima Si Mohammed4, Lysa Tagherset4, Coralie Tardivon4, Marie-Capucine Tellier4, François Téoulé8, Olivier Terrier10, Jean-François Timsit4, Théo Trioux4, Christelle Tual33, Sarah Tubiana4, Sylvie van der Werf34, Noémie Vanel35, Aurélie Veislinger33, Benoit Visseaux16, Aurélie Wiedemann26, Yazdan Yazdanpanah36 1Inserm UMR 1163, Paris, France. 2CHU Amiens, France. 3Hôpital Necker, Paris, France. 4Hôpital Bichat, Paris, France. 5Hôpital Louis Mourrier, Colombes, France. 6Institut Pasteur, Paris, France. 7F-CRIN Partners Platform, AP-HP, Université de Paris, Paris, France. 8Inserm UMR 1136, Paris, France. 9Drugs for Neglected Diseases Initiative, Geneva, Switzerland. 10Inserm UMR 1111, Lyon, France. 11Inserm Transfert, Paris, France. 12REACTing, Paris, France. 13Inserm UMR 1018, Paris, France. 14Inserm, Pôle Recherche Clinique, Paris, France. 15CIC 1403 Inserm-CHU Lille, Paris, France. 16Université de Paris, IAME, INSERM UMR 1137, AP-HP, University Hospital Bichat Claude Bernard, Virology, Paris, France. 17Inserm UMR 1219, Bordeaux, France. 18ANRS, Paris, France. 19CHU Lille, Lille, France. 20Pasteur Institute, Paris, France. 21Inserm sponsor, Paris, France. 22CHU Rouen–SMIT, Rouen, France. 23FCRIN INI-CRCT, Nancy, France. 24Inserm UMR 1137, Paris, France. 25Centre d'Investigation Clinique, Inserm CIC1426, Hôpital Robert Debré, Paris, France. 26Inserm UMR 955, Créteil, France; Vaccine Research Instiute (VRI), Paris, France. 27F-CRIN INI-CRCT, Paris, France. 28CHU de Bordeaux–SMIT, Bordeaux, France. 29RENARCI, Annecy, France. 30Hôpital Robert Debré, Paris, France. 31Hôpital Louis Mourier–Gynécologie, Colombes, France. 32University of Lorraine, Plurithematic Clinical Investigation Centre Inserm CIC-P; 1433, Inserm U1116, CHRU Nancy Hopitaux de Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France. 33Inserm CIC-1414, Rennes, France. 34Institut Pasteur, UMR 3569 CNRS, Université de Paris, Paris, France. 35Hôpital la Timone, Marseille, France. 36Bichat–SMIT, Paris, France. ; CoV-Contact Cohort Loubna Alavoine1, Karine K. A. Amat2, Sylvie Behillil3, Julia Bielicki4, Patricia Bruijning5, Charles Burdet6, Eric Caumes7, Charlotte Charpentier8, Bruno Coignard9, Yolande Costa1, Sandrine Couffin-Cadiergues10, Florence Damond8, Aline Dechanet11, Christelle Delmas10, Diane Descamps8, Xavier Duval1, Jean-Luc Ecobichon1, Vincent Enouf3, Hélène Espérou10, Wahiba Frezouls1, Nadhira Houhou11, Emila Ilic-Habensus1, Ouifiya Kafif11, John Kikoine11, Quentin Le Hingrat8, David Lebeaux12, Anne Leclercq1, Jonathan Lehacaut1, Sophie Letrou1, Bruno Lina13, Jean-Christophe Lucet14, Denis Malvy15, Pauline Manchon11, Milica Mandic1, Mohamed Meghadecha16, Justina Motiejunaite17, Mariama Nouroudine1, Valentine Piquard11, Andreea Postolache11, Caroline Quintin1, Jade Rexach1, Layidé Roufai10, Zaven Terzian11, Michael Thy18, Sarah Tubiana1, Sylvie van der Werf3, Valérie Vignali1, Benoit Visseaux8, Yazdan Yazdanpanah14 1Centre d'Investigation Clinique, Inserm CIC 1425, Hôpital Bichat Claude Bernard, APHP, Paris, France. 2IMEA Fondation Léon M'Ba, Paris, France. 3Institut Pasteur, UMR 3569 CNRS, Université de Paris, Paris, France. 4University of Basel Children's Hospital. 5Julius Center for Health Sciences and Primary Care, Utrecht, Netherlands. 6Université de Paris, IAME, Inserm UMR 1137, F-75018, Paris, France, Hôpital Bichat Claude Bernard, APHP, Paris, France. 7Hôpital Pitiè Salpétriere, APHP, Paris. 8Université de Paris, IAME, INSERM UMR 1137, AP-HP, University Hospital Bichat Claude Bernard, Virology, Paris, France. 9Santé Publique France, Saint Maurice, France. 10Pole Recherche Clinique, Inserm, Paris, France. 11Hôpital Bichat Claude Bernard, APHP, Paris, France. 12APHP, Paris, France. 13Virpath Laboratory, International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France. 14IAME Inserm UMR 1138, Hôpital Bichat Claude Bernard, APHP, Paris, France. 15Service des Maladies Infectieuses et Tropicales; Groupe Pellegrin-Place Amélie-Raba-Léon, Bordeaux, France. 16Hôpital Hotel Dieu, APHP, Paris, France. 17Service des Explorations Fonctionnelles, Hôpital Bichat–Claude Bernard, APHP, Paris, France. 18Center for Clinical Investigation, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France. ; Amsterdam UMC Covid-19 Biobank Michiel van Agtmael1, Anna Geke Algera2, Frank van Baarle2, Diane Bax3, Martijn Beudel4, Harm Jan Bogaard5, Marije Bomers1, Lieuwe Bos2, Michela Botta2, Justin de Brabander6, Godelieve de Bree6, Matthijs C. Brouwer4, Sanne de Bruin2, Marianna Bugiani7, Esther Bulle2, Osoul Chouchane1, Alex Cloherty3, Paul Elbers2, Lucas Fleuren2, Suzanne Geerlings1, Bart Geerts8, Theo Geijtenbeek9, Armand Girbes2, Bram Goorhuis1, Martin P. Grobusch1, Florianne Hafkamp9, Laura Hagens2, Jorg Hamann10, Vanessa Harris1, Robert Hemke11, Sabine M. Hermans1, Leo Heunks2, Markus W. Hollmann8, Janneke Horn2, Joppe W. Hovius1, Menno D. de Jong12, Rutger Koning4, Niels van Mourik2, Jeaninne Nellen1, Frederique Paulus2, Edgar Peters1, Tom van der Poll1, Benedikt Preckel8, Jan M. Prins1, Jorinde Raasveld2, Tom Reijnders1, Michiel Schinkel1, Marcus J. Schultz2, Alex Schuurman13, Kim Sigaloff1, Marry Smit2, Cornelis S. Stijnis1, Willemke Stilma2, Charlotte Teunissen14, Patrick Thoral2, Anissa Tsonas2, Marc van der Valk1, Denise Veelo8, Alexander P.J. Vlaar15, Heder de Vries2, Michèle van Vugt1, W. Joost Wiersinga1, Dorien Wouters16, A. H. (Koos) Zwinderman17, Diederik van de Beek4* 1Department of Infectious Diseases, Amsterdam UMC, Amsterdam, Netherlands. 2Department of Intensive Care, Amsterdam UMC, Amsterdam, Netherlands. 3Experimental Immunology, Amsterdam UMC, Amsterdam, Netherlands. 4Department of Neurology, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, Netherlands. 5Department of Pulmonology, Amsterdam UMC, Amsterdam, Netherlands. 6Department of Infectious Diseases, Amsterdam UMC, Amsterdam, Netherlands. 7Department of Pathology, Amsterdam UMC, Amsterdam, Netherlands. 8Department of Anesthesiology, Amsterdam UMC, Amsterdam, Netherlands. 9Department of Experimental Immunology, Amsterdam UMC, Amsterdam, Netherlands. 10Amsterdam UMC Biobank Core Facility, Amsterdam UMC, Amsterdam, Netherlands. 11Department of Radiology, Amsterdam UMC, Amsterdam, Netherlands. 12Department of Medical Microbiology, Amsterdam UMC, Amsterdam, Netherlands. 13Department of Internal Medicine, Amsterdam UMC, Amsterdam, Netherlands. 14Neurochemical Laboratory, Amsterdam UMC, Amsterdam, Netherlands. 15Department of Intensive Care, Amsterdam UMC, Amsterdam, Netherlands. 16Department of Clinical Chemistry, Amsterdam UMC, Amsterdam, Netherlands. 17Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, Amsterdam, Netherlands. 18Department of Neurology, Amsterdam UMC, Amsterdam, Netherlands. *Leader of the AMC Consortium. ; COVID Human Genetic Effort Laurent Abel1, Alessandro Aiuti2, Saleh Al Muhsen3, Fahd Al-Mulla4, Mark S. Anderson5, Andrés Augusto Arias6, Hagit Baris Feldman7, Dusan Bogunovic8, Alexandre Bolze9, Anastasiia Bondarenko10, Ahmed A. Bousfiha11, Petter Brodin12, Yenan Bryceson12, Carlos D. Bustamante13, Manish Butte14, Giorgio Casari15, Samya Chakravorty16, John Christodoulou17, Elizabeth Cirulli9, Antonio Condino-Neto18, Megan A. Cooper19, Clifton L. Dalgard20, Alessia David21, Joseph L. DeRisi22, Murkesh Desai23, Beth A. Drolet24, Sara Espinosa25, Jacques Fellay26, Carlos Flores27, Jose Luis Franco28, Peter K. Gregersen29, Filomeen Haerynck30, David Hagin31, Rabih Halwani32, Jim Heath33, Sarah E. Henrickson34, Elena Hsieh35, Kohsuke Imai36, Yuval Itan8, Timokratis Karamitros37, Kai Kisand38, Cheng-Lung Ku39, Yu-Lung Lau40, Yun Ling41, Carrie L. Lucas42, Tom Maniatis43, Davoud Mansouri44, Laszlo Marodi45, Isabelle Meyts46, Joshua Milner47, Kristina Mironska48, Trine Mogensen49, Tomohiro Morio50, Lisa FP. Ng51, Luigi D. Notarangelo52, Antonio Novelli53, Giuseppe Novelli54, Cliona O'Farrelly55, Satoshi Okada56, Tayfun Ozcelik57, Rebeca Perez de Diego58, Anna M. Planas59, Carolina Prando60, Aurora Pujol61, Lluis Quintana-Murci62, Laurent Renia63, Alessandra Renieri64, Carlos Rodríguez-Gallego65, Vanessa Sancho-Shimizu66, Vijay Sankaran67, Kelly Schiabor Barrett9, Mohammed Shahrooei68, Andrew Snow69, Pere Soler-Palacín70, András N. Spaan71, Stuart Tangye72, Stuart Turvey73, Furkan Uddin74, Mohammed J. Uddin75, Diederik van de Beek76, Sara E. Vazquez77, Donald C. Vinh78, Horst von Bernuth79, Nicole Washington9, Pawel Zawadzki80, Helen C. Su52, Jean-Laurent Casanova81 1INSERM U1163, University of Paris, Imagine Institute, Paris, France. 2San Raffaele Telethon Institute for Gene Therapy, IRCCS Ospedale San Raffaele, Milan, Italy. 3King Saud University, Riyadh, Saudi Arabia. 4Kuwait University, Kuwait City, Kuwait. 5University of California, San Francisco, San Francisco, CA, USA. 6Universidad de Antioquia, Group of Primary Immunodeficiencies, Antioquia, Colombia. 7The Genetics Institute, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 8Icahn School of Medicine at Mount Sinai, New York, NY, USA. 9Helix, San Mateo, CA, USA. 10Shupyk National Medical Academy for Postgraduate Education, Kiev, Ukraine. 11Clinical Immunology Unit, Pediatric Infectious Disease Departement, Faculty of Medicine and Pharmacy, Averroes University Hospital; LICIA Laboratoire d'Immunologie Clinique, d'Inflammation et d'Allergie, Hassann Ii University, Casablanca, Morocco. 12Karolinska Institute, Stockholm, Sweden. 13Stanford University, Stanford, CA, USA. 14University of California, Los Angeles, CA, USA. 15Medical Genetics, IRCCS Ospedale San Raffaele, Milan, Italy. 16Emory University Department of Pediatrics and Children's Healthcare of Atlanta, Atlanta, GA, USA. 17Murdoch Children's Research Institute, Victoria, Australia. 18University of São Paulo, São Paulo, Brazil. 19Washington University School of Medicine, St. Louis, MO, USA. 20The American Genome Center; Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 21Centre for Bioinformatics and System Biology, Department of Life Sciences, Imperial College London, South Kensington Campus, London, UK. 22University of California, San Francisco, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA. 23Bai Jerbai Wadia Hospital for Children, Mumbai, India. 24School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA. 25Instituto Nacional de Pediatria (National Institute of Pediatrics), Mexico City, Mexico. 26Swiss Federal Institute of Technology Lausanne, Lausanne, Switzerland. 27Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Canarian Health System, Santa Cruz de Tenerife, Spain. 28University of Antioquia, Medellín, Colombia. 29Feinstein Institute for Medical Research, Northwell Health USA, Manhasset, NY, USA. 30Department of Paediatric Immunology and Pulmonology, Centre for Primary Immunodeficiency Ghent (CPIG), PID Research Lab, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Edegem, Belgium. 31The Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. 32Sharjah Institute of Medical Research, College of Medicine, University of Sharjah, Sharjah, UAE. 33Institute for Systems Biology, Seattle, WA, USA. 34Children's Hospital of Philadelphia, Philadelphia, PA, USA. 35Anschutz Medical Campus, Aurora, CO, USA. 36Riken, Tokyo, Japan. 37Hellenic Pasteur Institute, Athens, Greece. 38University of Tartu, Tartu, Estonia. 39Chang Gung University, Taoyuan County, Taiwan. 40The University of Hong Kong, Hong Kong, China. 41Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. 42Yale School of Medicine, New Haven, CT, USA. 43New York Genome Center, New York, NY, USA. 44Shahid Beheshti University of Medical Sciences, Tehran, Iran. 45Semmelweis University Budapest, Budapest, Hungary. 46KU Leuven, Department of Immunology, Microbiology and Transplantation, Leuven, Belgium. 47Columbia University Medical Center, New York, NY, USA. 48University Clinic for Children's Diseases, Skopje, North Macedonia. 49Aarhus University, Aarhus, Denmark. 50Tokyo Medical & Dental University Hospital, Tokyo, Japan. 51Singapore Immunology Network, Singapore. 52National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. 53Bambino Gesù Children's Hospital, Rome, Italy. 54Department of Biomedicine and Prevention, University of Rome "Tor Vergata," Rome, Italy. 55Trinity College, Dublin, Ireland. 56Hiroshima University, Hiroshima, Japan. 57Bilkent University, Ankara, Turkey. 58Laboratory of Immunogenetics of Human Diseases, Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz Hospital, Madrid, Spain. 59IIBB-CSIC, IDIBAPS, Barcelona, Spain. 60Faculdades Pequeno Príncipe e Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Brazil. 61Neurometabolic Diseases Laboratory, IDIBELL–Hospital Duran I Reynals; Catalan Institution for Research and Advanced Studies (ICREA); CIBERER U759, ISCiii Madrid Spain, Barcelona, Spain. 62Institut Pasteur (CNRS UMR2000) and Collège de France, Paris, France. 63Infectious Diseases Horizontal Technology Center and Singapore Immunology Network, Agency for Science Technology (A*STAR), Singapore. 64Medical Genetics, University of Siena, Siena, Italy; Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Italy; GEN-COVID Multicenter Study. 65Hospital Universitario de Gran Canaria Dr. Negrín, Canarian Health System, Canary Islands, Spain. 66Imperial College London, London, UK. 67Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. 68Saeed Pathobiology and Genetic Lab, Tehran, Iran. 69Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 70Hospital Universitari Vall d'Hebron, Barcelona, Spain. 71University Medical Center Utrecht, Amsterdam, The Netherlands. 72Garvan Institute of Medical Research, Sydney, Australia. 73The University of British Columbia, Vancouver, Canada. 74Holy Family Red Crescent Medical College; Centre for Precision Therapeutics, NeuroGen Children's Healthcare; Genetics and Genomic Medicine Centre, NeuroGen Children's Healthcare, Dhaka, Bangladesh. 75Mohammed Bin Rashid University of Medicine and Health Sciences, College of Medicine, Dubai, UAE; The Centre for Applied Genomics, Department of Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada. 76Amsterdam UMC, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam, The Netherlands. 77University of California, San Francisco, CA, USA. 78McGill University Health Centre, Montreal, Canada. 79Charité–Berlin University Hospital Center, Berlin, Germany. 80Molecular Biophysics Division, Faculty of Physics, A. Mickiewicz University, Uniwersytetu Poznanskiego 2, Poznań, Poland. 81Rockefeller University, Howard Hughes Medical Institute, Necker Hospital, New York, NY, USA. *Leaders of the COVID Human Genetic Effort. ; NIAID-USUHS/TAGC COVID Immunity Group Huie Jing1,2, Wesley Tung1,2, Christopher R. Luthers3, Bradly M. Bauman3, Samantha Shafer2,4, Lixin Zheng2,4, Zinan Zhang2,4, Satoshi Kubo2,4, Samuel D. Chauvin2,4, Kazuyuki Meguro1,2, Elana Shaw1,2, Michael Lenardo2,4, Justin Lack5, Eric Karlins6, Daniel M. Hupalo7, John Rosenberger7, Gauthaman Sukumar7, Matthew D. Wilkerson7, Xijun Zhang7 1Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. 2NIAID Clinical Genomics Program, National Institutes of Health, Bethesda, MD, USA. 3Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 4Laboratory of Immune System Biology, Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA. 5NIAID Collaborative Bioinformatics Resource, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA. 6Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, NIAID, NIH, Bethesda, MD, USA. 7The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. ; Clinical outcome upon infection with SARS-CoV-2 ranges from silent infection to lethal COVID-19. We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern TLR3- and IRF7-dependent type I interferon (IFN) immunity to influenza virus, in 659 patients with life-threatening COVID-19 pneumonia, relative to 534 subjects with asymptomatic or benign infection. By testing these and other rare variants at these 13 loci, we experimentally define LOF variants in 23 patients (3.5%), aged 17 to 77 years, underlying autosomal recessive or dominant deficiencies. We show that human fibroblasts with mutations affecting this pathway are vulnerable to SARS-CoV-2. Inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection. ; We thank the generous donation from Fisher Center for Alzheimer's Research Foundation for our research. The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute, the Rockefeller University, the St. Giles Foundation, the National Institutes of Health (NIH) (R01AI088364), the National Center for Advancing Translational Sciences (NCATS), NIH Clinical and Translational Science Award (CTSA) program (UL1 TR001866), a Fast Grant from Emergent Ventures, Mercatus Center at George Mason University, the Yale Center for Mendelian Genomics and the GSP Coordinating Center funded by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and U24HG008956), the French National Research Agency (ANR) under the "Investments for the Future" program (ANR-10-IAHU-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), the French Foundation for Medical Research (FRM) (EQU201903007798), the FRM and ANR GENCOVID project, ANRS-COV05, the Square Foundation, Grandir - Fonds de solidarité pour l'enfance, the SCOR Corporate Foundation for Science, Institut National de la Santé et de la Recherche Médicale (INSERM), the University of Paris. The French COVID Cohort study group was sponsored by Inserm and supported by the REACTing consortium and by a grant from the French Ministry of Health (PHRC 20-0424). Regione Lombardia, Italy (project "Risposta immune in pazienti con COVID-19 e co-morbidità"), and the Intramural Research Program of the NIAID, NIH. The laboratory of Genomes & Cell Biology of Disease is supported by "Integrative Biology of Emerging Infectious Diseases" (grant no. ANR-10-LABX-62-IBEID), the "Fondation pour la Recherche Medicale" (grant FRM - EQU202003010193), the "Agence Nationale de la Recherche" (ANR FLASH COVID project IDISCOVR cofounded by the "Fondation pour la Recherche Médicale"), University of Paris ("Plan de Soutien Covid-19": RACPL20FIR01-COVID-SOUL). IM is a senior clinical investigator with the FWO Vlaanderen; IM and LM are supported by FWO G0C8517N – GOB5120N. The VS team was supported by "Agence Nationale de la Recherche" (ANR-17-CE15-0003, ANR-17-CE15-0003-01), and by Université de Paris "PLAN D'URGENCE COVID19". LK was supported by a fellowship from the French Ministry of Research. VS-S is supported by a UKRI Future Leaders Fellowship (MR/S032304/1). SZA-M is supported by the Elite Journals Program at King Saud University through grant number PEJP-16-107. JM lab is supported by Columbia University COVID biobank and grant: UL1TR001873. Work in the Laboratory of Virology and Infectious Disease was supported by NIH grants P01AI138398-S1, 2U19AI111825, and R01AI091707-10S1, a George Mason University Fast Grant, and the G. Harold and Leila Y. Mathers Charitable Foundation. JLP is supported by a European Molecular Biology Organization Long-Term Fellowship (ALTF 380-2018). Work at the Neurometabolic Diseases Laboratory received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 824110 (EasiGenomics grant COVID-19/ PID12342) to A.P., and Roche and Illumina Covid Match Funds to M.G. C.R.G and colleagues are supported by cInstituto de Salud Carlos III (COV20_01333 and COV20_01334), Spanish Ministry of Science and Innovation, with the funding of European Regional Development Fund-European Social Fund -FEDER-FSE; (RTC-2017-6471-1; AEI/FEDER, UE), and Cabildo Insular de Tenerife (CGIEU0000219140 and "Apuestas científicas del ITER para colaborar en la lucha contra la COVID-19"). D.C.V. is supported by the Fonds de la recherche en santé du Québec clinician-scientist scholar program. Helen Su is adjunct faculty at the University of Pennsylvania. A-L.N. was supported by the Foundation Bettencourt Schueller. The Amsterdam UMC Covid-19 Biobank was funded by the Netherlands Organization for Health Research and Development (ZonMw, NWO-vici 91819627), The Corona Research Fund (Amsterdam UMC), Dr. J. C. Vaillantfonds, and Amsterdam UMC. Work on COVID-19 at the AG-S lab is partly supported by NIH supplements to grants U19AI135972, U19AI142733 and R35 HL135834, and to contract HHSN272201800048C, by a DoD supplement to grant W81XWH-20-1-0270, by DARPA project HR0011-19-2-0020, by CRIP (Center for Research on Influenza Pathogenesis), a NIAID funded Center of Excellence for Influenza Research and Surveillance (CEIRS, contract HHSN272201400008C), by an NIAID funded Collaborative Influenza Vaccine Innovation Center (SEM-CIVIC, contract 75N93019C00051) and by the generous support of the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611(5384)) and anonymous donors. The Virscan analysis presented in fig. S11 was performed with financial support from Sidra Medicine ; Peer reviewed
ABSTRAK Penelitian ini bertujuan untuk menguji dan menganalisis Pengaruh Iklan Di Sosial Media, Persepsi Kualitas, EWOM dan Variasi Produk pada Minat Beli Ulang Produk Janji Jiwa Pada Followers Instagram Janji Jiwa Di Kota Pontianak. Bentuk dari penelitian ini adalah penelitian Asosialtif Kausal. Populasinya ialah seluruh followers Instagram janji jiwa di kota Pontianak. Sampel yang diambil pada penelitian ini berjumlah 100 orang dengan Teknik penarikan sampel menggunakan purposive sampling. Data diambil melalui metode kuesioner dengan menggunakan skala likert. Teknik analisis yang digunakan adalah analisis regresi linear berganda. Berdasarkan hasil penelitian menunjukkan bahwa iklan di sosial media dan variasi produk berpengaruh positif dan signifikan terhadap minat beli ulang. Sedangkan, persepsi kualitas dan EWOM berpengaruh positif namun tidak signifikan terhadap minat beli ulang.Kata Kunci: iklan di sosial media, persepsi kualitas, EWOM, variasi produk, dan minat beli ulang. DAFTAR PUSTAKA Alkatiri Suhailah, Tumbel Altje L, Roring ferdy (2017). Pengaruh daya Tarik Iklan dan potongan Harga terhadap Minat beli Konsumen pada Matahari Departement store Manado Town Square: Jurnal EMBA. Vol. 5. No. 2, Juni 2017 Andita Astrid C (2017). Pengaruh Iklan, Harga, Dan Kualitas Produk Terhadap Minat Beli Ulang Konsumen: Fakultas Ekonomi Universitas Sanata Dharma Yogyakarta 2017 Andriadi Akmal, Untarini Nindria (2013). Pengaruh Persepsi Kualitas Layanan Dan Citra Merek Telkom Flexi Terhadap Niat Beli Ulang: Jurnal Ilmu Manajemen. Volume 1 Nomor 2 Maret 2013 Anggraeni Jenni, Paramita Patricia D, Warso M M (2016). Pengaruh Keanekaragaman Produk, Kualitas Pelayanan dan Store Atmosphere terhadap Impulse Buying di Butik Cassanova Semarang: Journal of Management. Vol. 2. No. 2, Maret 2016 Anoraga, Pandji (2000). Manajemen Bisnis. Jakarta: PT. Rineka Cipta Arfimasri, Yulhan (2016). Pengaruh Keragaman Menu dan Persepsi Harga terhadap Minat Beli Konsumen pada Rumah Makan Aut Duri Sumani Kecamatan X Koto Singkarak Kabupaten Solok Sumbar: Jurnal Sosial dan Ilmu Ekonomi. Vol. IV. No. 01, 2019 Arif M. Erfan (2019). The Influence Of Electronic Word Of Mouth (Ewom), Brand Image, And Price On Re-Purchase Intention Of Airline Customers: Journal of Applied Management (JAM). Volume 17 Number 2, June 2019 Ariffin Shahira, Yusof Jamaliah Mohd, Putit Lennora, Shah Mohd Izwan Azalan (2016). Factors Influencing Perceived Quality and Repurchase Intention Towards Green Products: Faculty of Business Management, Universiti Teknologi MARA. Procedia Economics And Finance 37, 2016 Ariyani Efi D (2011). Pengaruh Keragaman Produk dan Pelayanan terhadap Citra Perusahaan pada Swalayan Aneka Jaya Boja: Fakultas Ekonomi Universitas Negeri Semarang Assauri Sofjan, S.E., M.B.A (2011). Manajemen Pemasaran: Ed.11 Basu Swasta&Sukotjo (2000). Manajemen Pemasaran Modern. Yogyakarta: Liberty Basu Swasta&T. Hani Handoko (2016). Manajemen Pemasaran Analisis Perilaku Konsumen. Edisi Pertama. BPFE, Yogyakarta Cahyono, F. D, Kusumawati. A, Kumadji. S (2016). Analisis Faktor- Faktor Pembentuk Electronic Word of Mouth (EWOM) dan Pengaruhnya terhadap Minat Beli: Jurnal Administrasi Bisnis (JAB). Vol. 37. No. 1, 2016Cravens D.W & Piercy N.F (2013). Strategic Marketing, 10th Edition. Singapore: McGrow-Hill Companies,Inc Fandy Tjiptono (2005). Strategi Pemasaran. Andi Offset. Yogyakarta Faradinah Isti, H Budi Leonardo, Minarsih Maria M (2016). Analisis Pengaruh Variasi Produk, Fasilitas, Dan Kualitas Pelayanan Terhadap Minat Beli Ulang Konsumen Pada Indonesian Coffeeshop Semarang (Icos Café): Journal Of Management. Volume 2 No.2 Maret 2016 Ghozali, I (2013). Aplikasi Analisis Multivariate Dengan Pogram IBM SPSS 21. Semarang: Badan Penerbit Universitas Diponegoro Indika Deru. R, Jovita Cindy (2017). Media Sosial Instagram sebagai Sarana Promosi untuk Meningkatkan Minat Beli Konsumen: Jurnal Bisnis Terapan. Vol. 1. No. 1, Juni 2017 Indriyo Gitosudarmo, M.Com. (Hons). (2014). Manajemen Pemasaran: Ed.2 Instagram (2020). Kopi Janji Jiwa. Diakses Pada 12 Februari 2020 Pukul 13.:05 WIB. http://www.istagram.com/p/B_T6SK6hxqh/?igshid=ph2vx9q6uez5 Instagram (2020). Kopi Janji Jiwa. Diakses Pada 12 Februari 2020 Pukul 14:45 WIB. http://www.instagram.com/p/B8ndAlgh-pu/?igshid=c6ifdivol252 Instagram (2020). Kopi Janji Jiwa. Diakses Pada 20 Oktober 2020 Pukul 21:16 WIB. http://www.instagram.com/p/CGJoaQhgM01/?igshid=i9pryyomhug Jalilvand Mohammad Reza, Samiei Neda ( 2012). The Effect of Electronic word Of Mouth on Brand Image and Puchase Intention An Empirical Study in the Automobile Industry in Iran: Marketing Intelligence & Planning. Vol. 30. No. 4, 2012 Kartika Eric Kusnadi (2014). Pengaruh Bauran Pemasaran Terhadap Niat Beli Ulang Sepeda Motor Honda Kategori Sport Mid: E-Journal Graduate Unpar Part A : Economics. Vol. 1, No. 2, 2014 Keller, Kevin Lane. 2003. Strategic Brand Management, Building, Measuring, and managing Brand Equity. New Jersey: Prentice Hall. Kopi Janji Jiwa (2019). Diakses Pada Tanggal 12 Februari 2020 Pukul 11:48 WIB http://golekrowo.blogspot.com/2019/06/kopi-janji-jiwa-bertahan-dengan-racikan.html?m=1 Kotler. P & Armstrong, G. (2012). Prinsip-prinsip pemasaran: (Ed 13). Jilid 1. Jakarta : Erlangga. Kotler.P & Keller K.L. (2018). Manajemen Pemasaran: (Ed 13). Jilid 1. Jakarta : Erlangga Kesumawati Nila, M.Si, Allen Marga Retta, M.Si, Novita Sari, M.Pd. ( 2017). Pengantar Statistika Penelitian: Ed.1 Kusumanegara Erlangga Tahta (2012). Analisis Pengaruh Harga, Keragaman Produk, dan Kualitas Pelayanan terhadap Kepuasan Konsumen dalam Melakukan Pembelian di Baskin Robbins Ice Cream Mall Ciputra Semarang: Fakultas Ekonomi dan Bisnis Universitas Diponegoro Semarang Matute Jorge (2016). The influence of EWOM characteristics on online repurchase intention Mediating roles of trust and perceived usefulness: Online Information Review. Vol. 40 No. 7, 2016 Menu Kopi Janji Jiwa ( 2019). Diakses pada tanggal 12 februari 2020 pukul 11:53 WIBhttps://www.google.com/search?q=menu+kopi+janji+jiwa+pontianak&safe=strict&client=ms-android-xiaomi-revl&prmd=ivn&sxsrf=ACYBGNRLxBAppyrXQKAOdfdxUJlk1b0Czg:1573270681893&source=lnms&tbm=isch&sa=X&ved=2ahUKEwiuvISBmtzlAhWDfysKHdNkDV8Q_AUoAXoECA0QAQ&cshid=1573270759165&biw=360&bih=667&dpr=2#imgrc+Oe_d3WFr-uV-vM Ningsih Evi Septia (2017). Analisis Pengaruh Persepsi Harga Dan Persepsi Kualitas Produk Terhadap Minat Beli Baju Eceran Di Solo Square: Program Studi Manajemen Fakultas Ekonomi Dan Bisnis Universitas Muhammadiyah Surakarta 2017 Priyatno (2014). SPSS 22 Pengolahan Data Terpraktis. Yogyakarta: ANDI Purborini, Ayu&Wibisono, Totok (2012). Analisis Pengaruh Kualitas Produk, Daya Tarik Iklan, Dan Persepsi Harga Terhadap Keputusan Pembelian Kosnumen Pada Produk Motor Yamaha Mio (Studi Kasus Pada Mahasiswa Di Universitas Semarang). Jurnal Q-Man, Vol.2,(No.2) Puspitasari Diana (2006). Analisis Pengaruh Persepsi Kualitas dan Kepuasan Pelanggan Terhadap Minat Beli Ulang (Studi Kasus Pada Maskapai Penerbangan Garuda Keberangkatan Semarang): Program Studi Magister Manajemen Program Pasca Sarjana Universitas Diponegoro Semarang 2006 Prawira M. Yudha, Butarbutar M, Sherly & Nainggolan Lora E (2019). Pengaruh Iklan Terhadap Minat Beli Ulang Dengan Persepsi Konsumen Sebagai Variable Intervening Pada Café Coffee Time And Seafood Mermatasiantar. Jurnal Manajemen Program Studi Manajemen STIE Sulta Agung Vol.5- No.2, Desember 2019(Hlm 48-60) Prayitno, D (2014). Spss 22 Pengolah Data Terpraktis. Yogyakarta: Andi Raharjo, S (2013). Belajar Praktek Analisis Multivariate Dengan Spss. Klaten: E-Book Di Download Dari Http://Www.Konsistensi.Com Rainy Adila, Widayanto (2019). Pengaruh Keragaman Produk Dan E-Service Quality Terhadap Minat Beli Ulang Melalui Kepuasan Konsumen (Studi Pada Mahasiswa Universitas Diponegoro Pelanggan Zalora). Diponegoro Journal Of Social And Politic Tahun 2019 Rambitan Pratiwi A (2018). Pengaruh Iklan Bukalapak Pada Situs Youtube Dan Gaya Hidup Di Era Digital Terhadap Minat Beli Ulang Di Toko Online Bukalapak: Fakultar Ekonomi Universitas Sanata Dharma Yogyakarta 2018 Samuel Hatane, Lianto Adi S (2014). Analisis eWOM, Brand Image, Brand Trust dan Minat Beli Produk Smartphone di Surabaya: Jurnal Manajemen Pemasaran. Vol. 8. No. 2, Oktober 2014 Satria Arief Adi (2017) Pengaruh Harga, Promosi, dan Kualitas Produk terhadap Minat Beli Konsumen pada Perusahaan A-36. Jurnal Manajemen dan Start-Up Bisnis, Vol. 2 No. 1, April 2017 Sugiyono (2016). Metode Penelitian Pendekatan Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabeta Sundalangi Marchelyno, Mandey Silvya L, Jorie Rotinsulu J (2014). Kualitas Produk, Daya Tarik Iklan, dan Potongan Harga terhadap Minat Beli Konsumen pada Pizza Hut Manado: Jurnal EMBA. Vol. 2. No. 1, 2014 Utomo Galih Wahyu ( 2015 ) Pengaruh Iklan dan Potongan Harga Terhadap Citra Toko dan Dampaknya terhadap Niat Beli Konsumen Produk Smartfren Andromax di Surabaya. Sekolah Tinggi Ilmu Perbanas. Surabaya Whidya Utami, Christina (2006). Manajemen Ritel: Strategi Dan Implementasi Ritel Modern. Selemba Empat, Jakarta Widyatama, Rendra (2005). Pengantar periklanan. Jakarta: Buana Pustaka Indonesia Willy, Nurjannah Siti (2019). Pengaruh Kemasan Produk dan Rasa terhadap Minat Beli yang berdampak pada Keputusan Pembelian Pelanggan Minuman Energi. Jurnal Ilmu Manajemen. Vol. 9. No. 2 Juni 2019 Yaqian Zhou (2011). The Impact Of Customer-Based Brand Equity On Revisit Intentions: An Empirical Study Of Business And Leisure Travelers At Five Shanghai Budget Hotels. AU-GSB Ejournal (Online) Vol. 4. No. 1 Pp. 168-181 Yaziq (2008). Pemasaran Jasa: Konsep Dan Implementasi. Yogyakarta. Ekonisia Yuliana (2015). Pengaruh Variasi Produk dan Display Layout terhadap Minat Beli Konsumen Muslim di Toko Bandeng Juwana Erlina Semarang. Universitas Islam Negeri Walisongo. Semarang Yuwomo Hendro, Yuwana Syamswana (2017). Pengaruh Pelayanan dan Keragaman Produk terhadap Kepuasan Konsumeen pada Toko King di Malang: Jurnal Ekonomi Manajemen. Vol. 02. No. 1, Mei 2017 Zeithaml, V. A. dan Mario Jo Bitner (1996). Service Marketing. McGraw-Hill Companies Inc., New York.
ABSTRACTThis study aims to test and analyze the Influence of Advertising On Social Media, Quality Perception, EWOM and Product Variations on The Interest of Buying Back Soul Promise Products On Instagram Followers Of Soul Promise In Pontianak City. The form of this research is Tysal Asocialive research. The population is the entire Instagram followers of the promise of soul in pontianak city. The samples taken in this study amounted to 100 people with sample withdrawal techniques using purposive sampling. The data was taken through a questionnaire method using a likert scale. The analytical technique used is multiple linear regression analysis. Based on the results showed that advertising on social media and product variations have a positive and significant effect on re-purchase interest. Meanwhile, the perception of quality and EWOM has a positive but insignificant effect on re-purchase interest. Keywords: advertising on social media, quality perception, EWOM, product variations, and resending interest. Daftar Pustaka Alkatiri Suhailah, Tumbel Altje L, Roring ferdy (2017). Pengaruh daya Tarik Iklan dan potongan Harga terhadap Minat beli Konsumen pada Matahari Departement store Manado Town Square: Jurnal EMBA. Vol. 5. No. 2, Juni 2017 Andita Astrid C (2017). Pengaruh Iklan, Harga, Dan Kualitas Produk Terhadap Minat Beli Ulang Konsumen: Fakultas Ekonomi Universitas Sanata Dharma Yogyakarta 2017 Andriadi Akmal, Untarini Nindria (2013). Pengaruh Persepsi Kualitas Layanan Dan Citra Merek Telkom Flexi Terhadap Niat Beli Ulang: Jurnal Ilmu Manajemen. Volume 1 Nomor 2 Maret 2013 Anggraeni Jenni, Paramita Patricia D, Warso M M (2016). Pengaruh Keanekaragaman Produk, Kualitas Pelayanan dan Store Atmosphere terhadap Impulse Buying di Butik Cassanova Semarang: Journal of Management. Vol. 2. No. 2, Maret 2016 Anoraga, Pandji (2000). Manajemen Bisnis. Jakarta: PT. Rineka Cipta Arfimasri, Yulhan (2016). Pengaruh Keragaman Menu dan Persepsi Harga terhadap Minat Beli Konsumen pada Rumah Makan Aut Duri Sumani Kecamatan X Koto Singkarak Kabupaten Solok Sumbar: Jurnal Sosial dan Ilmu Ekonomi. Vol. IV. No. 01, 2019 Arif M. Erfan (2019). The Influence Of Electronic Word Of Mouth (Ewom), Brand Image, And Price On Re-Purchase Intention Of Airline Customers: Journal of Applied Management (JAM). Volume 17 Number 2, June 2019 Ariffin Shahira, Yusof Jamaliah Mohd, Putit Lennora, Shah Mohd Izwan Azalan (2016). Factors Influencing Perceived Quality and Repurchase Intention Towards Green Products: Faculty of Business Management, Universiti Teknologi MARA. Procedia Economics And Finance 37, 2016 Ariyani Efi D (2011). Pengaruh Keragaman Produk dan Pelayanan terhadap Citra Perusahaan pada Swalayan Aneka Jaya Boja: Fakultas Ekonomi Universitas Negeri Semarang Assauri Sofjan, S.E., M.B.A (2011). Manajemen Pemasaran: Ed.11 Basu Swasta&Sukotjo (2000). Manajemen Pemasaran Modern. Yogyakarta: Liberty Basu Swasta&T. Hani Handoko (2016). Manajemen Pemasaran Analisis Perilaku Konsumen. Edisi Pertama. BPFE, Yogyakarta Cahyono, F. D, Kusumawati. A, Kumadji. S (2016). Analisis Faktor- Faktor Pembentuk Electronic Word of Mouth (EWOM) dan Pengaruhnya terhadap Minat Beli: Jurnal Administrasi Bisnis (JAB). Vol. 37. No. 1, 2016Cravens D.W & Piercy N.F (2013). Strategic Marketing, 10th Edition. Singapore: McGrow-Hill Companies,Inc Fandy Tjiptono (2005). Strategi Pemasaran. Andi Offset. Yogyakarta Faradinah Isti, H Budi Leonardo, Minarsih Maria M (2016). Analisis Pengaruh Variasi Produk, Fasilitas, Dan Kualitas Pelayanan Terhadap Minat Beli Ulang Konsumen Pada Indonesian Coffeeshop Semarang (Icos Café): Journal Of Management. Volume 2 No.2 Maret 2016 Ghozali, I (2013). Aplikasi Analisis Multivariate Dengan Pogram IBM SPSS 21. Semarang: Badan Penerbit Universitas Diponegoro Indika Deru. R, Jovita Cindy (2017). Media Sosial Instagram sebagai Sarana Promosi untuk Meningkatkan Minat Beli Konsumen: Jurnal Bisnis Terapan. Vol. 1. No. 1, Juni 2017 Indriyo Gitosudarmo, M.Com. (Hons). (2014). Manajemen Pemasaran: Ed.2 Jalilvand Mohammad Reza, Samiei Neda ( 2012). The Effect of Electronic word Of Mouth on Brand Image and Puchase Intention An Empirical Study in the Automobile Industry in Iran: Marketing Intelligence & Planning. Vol. 30. No. 4, 2012 Kartika Eric Kusnadi (2014). Pengaruh Bauran Pemasaran Terhadap Niat Beli Ulang Sepeda Motor Honda Kategori Sport Mid: E-Journal Graduate Unpar Part A : Economics. Vol. 1, No. 2, 2014 Keller, Kevin Lane. 2003. Strategic Brand Management, Building, Measuring, and managing Brand Equity. New Jersey: Prentice Hall. Kotler. P & Armstrong, G. (2012). Prinsip-prinsip pemasaran: (Ed 13). Jilid 1. Jakarta : Erlangga. Kotler.P & Keller K.L. (2018). Manajemen Pemasaran: (Ed 13). Jilid 1. Jakarta : Erlangga Kesumawati Nila, M.Si, Allen Marga Retta, M.Si, Novita Sari, M.Pd. ( 2017). Pengantar Statistika Penelitian: Ed.1 Kusumanegara Erlangga Tahta (2012). Analisis Pengaruh Harga, Keragaman Produk, dan Kualitas Pelayanan terhadap Kepuasan Konsumen dalam Melakukan Pembelian di Baskin Robbins Ice Cream Mall Ciputra Semarang: Fakultas Ekonomi dan Bisnis Universitas Diponegoro Semarang Matute Jorge (2016). The influence of EWOM characteristics on online repurchase intention Mediating roles of trust and perceived usefulness: Online Information Review. Vol. 40 No. 7, 2016 Ningsih Evi Septia (2017). Analisis Pengaruh Persepsi Harga Dan Persepsi Kualitas Produk Terhadap Minat Beli Baju Eceran Di Solo Square: Program Studi Manajemen Fakultas Ekonomi Dan Bisnis Universitas Muhammadiyah Surakarta 2017 Priyatno (2014). SPSS 22 Pengolahan Data Terpraktis. Yogyakarta: ANDI Purborini, Ayu&Wibisono, Totok (2012). Analisis Pengaruh Kualitas Produk, Daya Tarik Iklan, Dan Persepsi Harga Terhadap Keputusan Pembelian Kosnumen Pada Produk Motor Yamaha Mio (Studi Kasus Pada Mahasiswa Di Universitas Semarang). Jurnal Q-Man, Vol.2,(No.2) Puspitasari Diana (2006). Analisis Pengaruh Persepsi Kualitas dan Kepuasan Pelanggan Terhadap Minat Beli Ulang (Studi Kasus Pada Maskapai Penerbangan Garuda Keberangkatan Semarang): Program Studi Magister Manajemen Program Pasca Sarjana Universitas Diponegoro Semarang 2006 Prawira M. Yudha, Butarbutar M, Sherly & Nainggolan Lora E (2019). Pengaruh Iklan Terhadap Minat Beli Ulang Dengan Persepsi Konsumen Sebagai Variable Intervening Pada Café Coffee Time And Seafood Mermatasiantar. Jurnal Manajemen Program Studi Manajemen STIE Sulta Agung Vol.5- No.2, Desember 2019(Hlm 48-60) Prayitno, D (2014). Spss 22 Pengolah Data Terpraktis. Yogyakarta: Andi Raharjo, S (2013). Belajar Praktek Analisis Multivariate Dengan Spss. Klaten: E-Book Di Download Dari Http://Www.Konsistensi.Com Rainy Adila, Widayanto (2019). Pengaruh Keragaman Produk Dan E-Service Quality Terhadap Minat Beli Ulang Melalui Kepuasan Konsumen (Studi Pada Mahasiswa Universitas Diponegoro Pelanggan Zalora). Diponegoro Journal Of Social And Politic Tahun 2019 Rambitan Pratiwi A (2018). Pengaruh Iklan Bukalapak Pada Situs Youtube Dan Gaya Hidup Di Era Digital Terhadap Minat Beli Ulang Di Toko Online Bukalapak: Fakultar Ekonomi Universitas Sanata Dharma Yogyakarta 2018 Samuel Hatane, Lianto Adi S (2014). Analisis eWOM, Brand Image, Brand Trust dan Minat Beli Produk Smartphone di Surabaya: Jurnal Manajemen Pemasaran. Vol. 8. No. 2, Oktober 2014 Satria Arief Adi (2017) Pengaruh Harga, Promosi, dan Kualitas Produk terhadap Minat Beli Konsumen pada Perusahaan A-36. Jurnal Manajemen dan Start-Up Bisnis, Vol. 2 No. 1, April 2017 Sugiyono (2016). Metode Penelitian Pendekatan Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabeta Sundalangi Marchelyno, Mandey Silvya L, Jorie Rotinsulu J (2014). Kualitas Produk, Daya Tarik Iklan, dan Potongan Harga terhadap Minat Beli Konsumen pada Pizza Hut Manado: Jurnal EMBA. Vol. 2. No. 1, 2014 Utomo Galih Wahyu ( 2015 ) Pengaruh Iklan dan Potongan Harga Terhadap Citra Toko dan Dampaknya terhadap Niat Beli Konsumen Produk Smartfren Andromax di Surabaya. Sekolah Tinggi Ilmu Perbanas. Surabaya Whidya Utami, Christina (2006). Manajemen Ritel: Strategi Dan Implementasi Ritel Modern. Selemba Empat, Jakarta Widyatama, Rendra (2005). Pengantar periklanan. Jakarta: Buana Pustaka Indonesia Willy, Nurjannah Siti (2019). Pengaruh Kemasan Produk dan Rasa terhadap Minat Beli yang berdampak pada Keputusan Pembelian Pelanggan Minuman Energi. Jurnal Ilmu Manajemen. Vol. 9. No. 2 Juni 2019 Yaqian Zhou (2011). The Impact Of Customer-Based Brand Equity On Revisit Intentions: An Empirical Study Of Business And Leisure Travelers At Five Shanghai Budget Hotels. AU-GSB Ejournal (Online) Vol. 4. No. 1 Pp. 168-181 Yaziq (2008). Pemasaran Jasa: Konsep Dan Implementasi. Yogyakarta. Ekonisia Yuliana (2015). Pengaruh Variasi Produk dan Display Layout terhadap Minat Beli Konsumen Muslim di Toko Bandeng Juwana Erlina Semarang. Universitas Islam Negeri Walisongo. Semarang Yuwomo Hendro, Yuwana Syamswana (2017). Pengaruh Pelayanan dan Keragaman Produk terhadap Kepuasan Konsumeen pada Toko King di Malang: Jurnal Ekonomi Manajemen. Vol. 02. No. 1, Mei 2017 Zeithaml, V. A. dan Mario Jo Bitner (1996). Service Marketing. McGraw-Hill Companies Inc., New York. Website: http://www.istagram.com/p/B_T6SK6hxqh/?igshid=ph2vx9q6uez5 http://www.instagram.com/p/B8ndAlgh-pu/?igshid=c6ifdivol252 http://www.instagram.com/p/CGJoaQhgM01/?igshid=i9pryyomhug http://golekrowo.blogspot.com/2019/06/kopi-janji-jiwa-bertahan-dengan-racikan.html?m=1https://www.google.com/search?q=menu+kopi+janji+jiwa+pontianak&safe=strict&client=ms-android-xiaomi-revl&prmd=ivn&sxsrf=ACYBGNRLxBAppyrXQKAOdfdxUJlk1b0Czg:1573270681893&source=lnms&tbm=isch&sa=X&ved=2ahUKEwiuvISBmtzlAhWDfysKHdNkDV8Q_AUoAXoECA0QAQ&cshid=1573270759165&biw=360&bih=667&dpr=2#imgrc+Oe_d3WFr-uV-vM
Integrity is fundamental to everyone involved in education – students, parents, teachers, lecturers, administrators and future employers, as well as the general public. It is hardly surprising therefore, that research on educational integrity continues to gather momentum, as evidenced by the growing number of conferences and seminars on this subject around the world. I am very pleased to report that while student cheating and plagiarism continue to be topics of interest, practitioners and researchers are also exploring the broader, social context and the changing, globalised and increasingly commercialised nature of education itself. The current issue of the International Journal for Educational Integrity is introduced by William Astore's Plenary Address from the Annual International Center for Academic Integrity Conference, held at Washington University in St Louis, Illinois in October this year. Astore spoke boldly to conference delegates of the 'wider dimensions of academic integrity', using anecdotes from his own experience as a military instructor at the Air Force Academy in Colorado Springs, and as a history professor at the Pennsylvania College of Technology. He convincingly argued that systemic breaches of integrity are far more harmful than individual lapses such as student cheating because they compromise the institution as a whole. In his Address, Astore was openly critical of the marketisation of higher education, a topic which was also explored at the 4th Asia-Pacific Conference on Educational Integrity: Creating an Inclusive Approach, held in September at the University of Wollongong in NSW, Australia. The four best refereed papers from the Asia-Pacific Conference are included in this issue of the IJEI. Kim awyer from the University of Melbourne, and Jackie Johnson and Mark Holub from the University of Western ustralia, provide a candid analysis of the decline in academic standards and integrity in Australian higher education. This paper provides a thorough overview of recent changes in Australian higher education. As Richard Davis commented in his review, "Critics of the modern university face an uphill task. Accused of advocating old, inefficient ways and lamenting a decadent past, they are easily silenced by self-satisfied colleagues enjoying their large research grants and consultancies. Some critics can do little more than condemn local personalities. All would be well if the vice-chancellor was less authoritarian or the university council less mean in its refusal of salary increases. The strength of the current paper lies in its remorseless analysis of the system which developed inexorably from the government's determination to educate more students while cutting its higher education costs. The 'new' corporate market-based university replaced the 'old' university dedicated to the ideals of free enquiry and education as an end in itself". Moving from the broad educational context to specific practices, the next four papers in this issue investigate issues of learning, teaching, assessment and adjudication. Clair Hughes from the University of Queensland addresses an apparent shortfall in Australian universities' implementation of 'Graduate Attributes' (GA), including the GA relating to ethical conduct. Hughes maintains that to authentically operationalise GAs, much more is needed than simply mapping specific attributes against existing programs and courses. Hughes argues for a whole of programme approach, the explicit inclusion of ethics in course teaching and assessment plans, and provides specific examples of how this may be achieved. Jon Yorke, Kathryn Lawson and Graham McMahon from Curtin University of Technology in Western Australia, ask how those who adjudicate breaches of academic integrity can reliably determine 'intent' in cases of plagiarism. The authors draw on a desktop study of institutional policies and procedures in 20 universities from Australia, US, Singapore, Hong Kong, India and the UK to analyse the way that 'intent' is defined and determined. Their findings indicate that despite the espoused significance of 'intent' in determining outcomes for alleged academic misconduct in many policies, there is inconsistency in the way that it is treated. The authors provide a preliminary series of 'probability factors' which might be used to determine 'intent' and call for further research in this little explored aspect of academic integrity. Grace McCarthy and Ann Rogerson from the University of Wollongong in NSW, Australia, share the results of a trial at the Sydney Business School where 61 international students were encouraged to use 'originality reports' provided by the software program Turnitin to assess the originality of their own work and thus avoid inadvertent plagiarism. In conjunction with hands-on support from teaching staff, students were permitted to submit as many drafts as necessary to Turnitin, with the result that all final submissions had a text match of 5% or less. As a consequence of the positive results of the trial, the use of Turnitin as a drafting mechanism, coupled with an extensive program of embedded support and supplementary workshops, has now been mandated for all subjects. The authors share further qualitative and quantitative data to support their thesis that "the use of text-matching software can be a powerful aid to help students improve their writing and to help academic staff identify potential plagiarism". The final paper in this issue is the only one not previously presented at one of the international conferences on academic integrity held during 2009. Mary Davis and Jude Carroll from Oxford Brookes University, using data collected over three years from cohorts of international students in the UK, also explore the role of text-matching software in plagiarism education, with a focus on the importance of formative feedback through tutorial intervention. As one part of an overall educative approach, students worked hand in hand with their tutors to read and interpret the Originality Reports of ungraded drafts of assignments prior to final submission. Students were also surveyed at the end of the module to ascertain their perceptions of the value of using Turnitin in this way. The data indicated that the approach taken at Oxford Brookes University resulted in reductions in the amount of plagiarism, over-reliance on sources, citations errors and insufficient paraphrasing. This study provides an example of best practice in the educational use of text-matching software and provides a potential counter to those who are concerned that the sole function of such software is to police and punish students. I hope that you enjoy this issue of the International Journal for Educational Integrity, and invite you to submit a paper for review directly to me at tracey.bretag@unisa.edu.au or respond to the Call for Papers for Volume 6(2) below. Tracey Bretag, IJEI Editor December 2009 Call for papers, Volume 6(2) 2010 Special issue of IJEI on 'digital technologies and educational integrity' Edited by Chris Moore and Ruth Walker This special issue seeks articles that address the impact of digital technologies on educational integrity. Many different terms have emerged in an attempt to capture the shifting terrain of media and users in various networked environments: 'social', 'participatory', 'user-generated' or simply 'new' media. Common to the online and interactive spaces of Web2.0 is the challenge of technologies and practices that are capable of changing the way we teach, learn, and share knowledge. How can we best engage and support students and colleagues coming to terms with the dynamics of these technologies and the development of new literacies? We are particularly interested in innovative research from scholars in cultural and media studies and/or the scholarship of teaching and learning, and welcome interest from the other disciplinary researchers, who might consider a broad range of questions about digital technologies that critically unpack the conversation about education integrity that goes beyond preoccupation with plagiarism and research ethics. Critical voices of concern, examples of best practice and consideration of the perceived impact of digital technology on institutional boundaries are keenly sought as is research exploring the collaborative approaches to social and participatory media that challenge conceptions about authorial identity and scholarly writing practices. Research examining the development of new literacies that celebrate the appropriation, adaptation and transformation of source material would fit well within the scope of this special issue. Abstract due date: 31 March 2010 Full paper deadline: 1 July 2010 Special issue release date: December 2010 Send all enquiries and 500 word abstract to the guest editors at ruth_walker@uow.edu.au With thanks to our reviewers in 2009: Kate Andre, University of South Australia Peter Bowden, University of Sydney Kylie Brass, University of Western Sydney Deborah Churchman, University of South Australia Geoffrey Crisp, University of Adelaide Richard Davis, University of Tasmania John Dearn, Australian National University Fiona Duggan Lawrence B. Ebert Teddi Fishman, Clemson University Neera Handa, University of Western Sydney Beverley Kokkin, University of South Australia Margaret Lightbody, University of Adelaide Nancy Matchett, University of Colorado Paul Moore, University of Wollongong Gerry Mullins, University of Adelaide Nicholas Proctor, University of South Australia Wendy Sutherland-Smith, Monash University Daniel Wueste, Clemson University
In: Library of Selected Cases from the Chinese Court
Chapter 1: Lianqi Development Co., Ltd. v. Shanghai Baoye Group Corp., Ltd., Sakai SIO International(Guangzhou)Co., Ltd. et al. (Appeal against Jurisdictional Objection in Dispute over Infringement of Patent for Invention): The Principle of "Two Conveniences" and the Mechanism of Leapfrog Appeal shall be Fully Considered when Confirming the Jurisdiction of Non-infringement and Infringement of Patent -- Chapter 2: Shanxi Coal International Energy Group Jincheng Co., Ltd. v. China CITIC Bank Co., Ltd. Xi'an Branch, Shaanxi Petroleum & Chemical Corporation Co., Ltd. (Dispute over Contract): In a Confirming Warehouse Transaction Without Real Trade Background, the Real Legal Relationship Among the Buyer, Seller, and the Bank Shall be Found to be the Relationship of Loan and Guaranty Contract -- Chapter 3: Xinjiang Longmei Energy Co. Ltd. v. Zheng X (Dispute over Equity Transfer Contract): Changed Circumstances Shall not Be Claimed to Rescind the Contract Concluded When a Party Clearly Knowing the Risk -- Chapter 4: Ping An Bank Co., Ltd. Beijing Branch, and Beijing Gold Exchange Co., Ltd. et al v. Hainan Jinfenghuang Hotspring Resort Co., Ltd., Beijing Xinyupeng Mechanical & Electrical Engineering Co., Ltd. et al (Dispute over Loan Contract): The Effect of Issuing a Blank Guaranty Contract Stamped with the Official Seal, and the Issue That a Guaranty Provider May Be Exempted Within the Scope of the Pledge Waived by Its Pledgee -- Chapter 5: China Nonferrous Metal Industry's Construction Co., Ltd. v. Hengfeng Bank Co., Ltd. Ningbo Branch and defendants in the first instance, Ningbo Zhong Ren Hong Electronics Co., Ltd. and Ningbo Gang Di Trade Co., Ltd. et al. (Disputes over the Issuing of Letter of Credit and the Right of Recourse) : Instruments Debtors Shall not Protest Against the Pledgee on the Ground of Protesting Against the Pledgor -- Chapter 6: Xinjiang Hua Cheng An Ju Real Estate Development Co., Ltd. v. China Railway Construction Bridge Engineering Bureau Group Co., Ltd. (Dispute over Contract for the Undertaking of Construction Projects): on Application of Good Faith Principle in Finding the Validity of Contract -- Chapter 7: LC Securities Co., Ltd. and Eastern Gold Jade Co., Ltd. v. Yunnan Xinglong Industry Co., Ltd. and Zhao X et al. (Dispute over a Suretyship Contract): The Scope of Security Liability Assumed by the Security Provider Shall be Limited to the Scope of the Principal Obligation -- Chapter 8: Bank of DaLian Co., Ltd. v. Dalian Branch of China Railway Modern Logistics Technology Co., Ltd. and Jinzhou Zuoyuan Sugar Foods Co., Ltd. et al. (Dispute over a Loan Contract): Pledge in Movable Property May not be Created by Possession Reformulation -- Chapter 9: Sichuan Zhongding Construction Engineering Co., Ltd. v. Zhu X and Natural Resources Bureau of Wulan County (Dispute over Contract for the Undertaking of Construction Projects): In a De Facto Juristic Relation, the Actual Builder May Claim Project Payments Directly with the Party Offering the Contract -- Chapter 10: Fujian Tinghu Real Estate Group Co., Ltd. v. Natural Resources Bureau of Xianyou County (Dispute over a Contract for Transfer of State-owned Construction Land Use Right): In Case of Breach of Contract due to Objective Reasons, the Liquidated Damages Clause Shall be Applied Primarily to Cover the Loss -- Chapter 11: Wang X V. Bazhou Sairui Machinery & Equipment Installation Co., Cao X(A) (Dispute over Change of Registration): The Claim of the Resigned Legal Representative for the Registration of the Change of the Legal Representative of Company Shall, Absent Other Remedies, Be Accepted by the Court -- Chapter 12: Peng X V. Chengdu Rural Commercial Bank Co., Ltd. Cuqiao Subbranch, Chen X, et al. (Dispute over Suretyship agreement): Impact on the Liability of Other Guarantors Involved of Creditor's Waiver in Mixed Security of Security in Rem as Provided by Debtor -- Chapter 13: Hubei YAS Commercial Chain Co., Ltd. V. Danyang Yongsheng Motor Transport Co., Ltd. (Dispute over Tort Liability): Criteria for the Determination of Erroneous Application for Property Preservation -- Chapter 14: Jiang X, Chen X, el al. V. Lin X, Weng X(A)., et al. (Dispute over Objection to the Enforcement of Judgment): Determination on the Time When the Seizure Ruling and the Notice of Assistance in Execution Take Effect -- Chapter 15: Huang X V. Xiamen Shuangrun Investment Management Co., Fenghe (China) Co. (the third party in the first instance), Hui'an County Rural Credit Cooperative (Dispute over the Objection by an Outsider to the Enforcement): The Requirements for the Valid Objection to the Execution by the Transferee of Equity -- Chapter 16: Guilin Zhangtai Industry Group Co., Ltd., Guangxi Lichengdong Investment Co., Ltd. et al (Enforcement Reconsideration of Dispute over Recovery of Financial Distressed Debt): Identification of Interest in Cases of Enforcement against Dispute over Recovery of Financial Distressed Debt -- Chapter 17: Zhou X v. Xiamen Baixiang Shouli E-Business Co., Ltd. (Dispute over Online Shopping Contract): Determination of the Basis for the Adjustment of Agreed Punitive Liquidated Damages. - Chapter 18: Yunnan Copper Co., Ltd. v. Kunming Wanbao Jiyuan Biotechnology Co., Ltd., Yunnan Zhongheng Innovation Investment Co., Ltd. etc (Dispute over Sale Contract): Identification of the Nature and Validity of Closed-loop Sale Contracts -- Chapter 19: Zhongkong Guorong New Energy Development Co., Ltd. v. Fuzhou Dade Industry Co., Ltd. (Dispute over Sale Contract): Determination and Application of Deposit-related Penalty Rules for Partial Performance of Contracts -- Chapter 20: Zhongrong Hengsheng Wood Industry Co., Ltd.(Beijing)v. Crosplus (Shanghai) Co., Ltd. and Nanjing Mengyang Furniture Sales Center (Dispute over Copyright Infringement): Elements for Copyright Protection of Works of Applied Art -- Chapter 21: JDB (China) Co., Ltd. v. Guangzhou Wanglaoji Health Industry Co., Ltd. (Dispute over False Advertising): Identification of False Advertising -- Chapter 22: Shandong Bittel Intelligent Technology Co., Ltd (Bittel) v. Jiangsu Zhongxun Digital Electronics Co., Ltd. (Dispute over Tortious Liability for Damages Arising from Malicious Prosecution in Intellectual Property Litigation): Standard for Assessing the Subjective Fault in Disputes over Damages Arising from Malicious Prosecution in Intellectual Property Litigation -- Chapter 23: Lacoste Company Limited v. Cartelo Pty Ltd. and Trademark Review and Adjudication Board of State Administration for Industry and Commerce of the People's Republic of China (Administrative Dispute over Trademark Disputes): Impact of Offshore Co-existence Agreements on Determining the Trademark Similarity -- Chapter 24: Xiamen Meetyou Co., Ltd. v. Beijing Kangzhilesi Network Technology Co., Ltd. and China National Intellectual Property Administration (Administrative Dispute over Request for Declaration of Trademark Invalidity): Whether the Trademark at Issue is the Sign "Not to be Used as Trademark" Falls within the Jurisdiction of People's Court to Review the Administrative Act or Conduct in Affirming and Authorizing the Trademark -- Chapter 25: Xiao X v. Seno LED Co., Ltd. (Dispute over Infringement of Patent for Invention): The Role of Interpretations of the Recorded Technical Effect upon the Patent Claims and Impact on the Principle of Equivalence -- Chapter 26: Medacor (Tianjin) Technology Co., Ltd. v. Sunshine (Tianjin) Group Co., Ltd., and Defendants in the First Instance, Wang A, Zhang A, et al. (Dispute over Infringement of Trade Secrets): How to Determine whether the Customer List Constitutes the Trade Secrets -- Chapter 27: Ningbo Beworth Textile Machinery Co., Ltd. v. Ningbo Cixing Company Limited (Dispute over License Contract for Technological Secrets): Handling of Cases involved both Criminal and Civil Proceedings related to Trade Secrets -- Chapter 28: VMI Holland B.V. and Cooper (Kunshan) Tire Co., Ltd. v. Safe-run Co., Ltd. (Dispute over Confirmation of Patent Non-infringement): Prerequisites for Confirming Patent Non-infringement -- Chapter 29: Alfa Laval Corporate A B v. China National Intellectual Property Administration and SWEP International A B (the Third Party in the First Instance) (Administrative Dispute over Invalid Patent for Invention): Determination of Modification of Patent Claims beyond Scope in Invalidity Declaration Proceedings -- Chapter 30: Shimano v. Sensah Smart Sports Equipment Co., Ltd. (Dispute over Infringement of Patent for Invention): Determination of Protection Scope of Functional Features -- Chapter 31: Shenzhen Jiedian Technology Co., Ltd. v. Shenzhen Laidian Technology Co., Ltd. and Anker Innovations Technology Co., Ltd. (Dispute over Infringement of Patent for Utility Models): Classification and Identification Standards of Technical Features in Patent Claims -- Chapter 32: Wartsila Finland Oy and Spliethoff's Bevrachtingskantoor B.V. v. Rongcheng Xixiakou Shipbuilding Co., Ltd. and Yingqin Engine (Shanghai) Co., Ltd. (Tort dispute over the sale and purchase of marine equipment): Mere interest in the performance of a contract does not in principle fall within the scope of application of the law of tort liability -- Chapter 33: Shanghai Salvage Company under the Ministry of Transport v. Provence Shipowner 2008-1 Ltd, CMA CGM SA, et. al (Dispute over salvage at sea and ship pollution damage liabilities): How to distinguish the costs of preventive measures and the costs of salvage measures, determine the subject avoiding liability in ship collision and oil spill pollution incidents, and identify restricted and unrestricted maritime compensation claims -- Chapter 34: Bank of China Limited, Henan Branch v. UBAF (Hong Kong) Ltd. (Dispute over independent guarantee): How to determine independent guarantee fraud by a prima facie complying demand due to abuse of claim for payment -- Chapter 35: Evergreen Marine (Singapore) Pte. Ltd. v. .
Verfügbarkeit an Ihrem Standort wird überprüft
Dieses Buch ist auch in Ihrer Bibliothek verfügbar:
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabling the responsible sharing of clinical and genomic data through both harmonized data aggregation and federated approaches. The decreasing cost of genomic sequencing (along with other genome-wide molecular assays) and increasing evidence of its clinical utility will soon drive the generation of sequence data from tens of millions of humans, with increasing levels of diversity. In this perspective, we present the GA4GH strategies for addressing the major challenges of this data revolution. We describe the GA4GH organization, which is fueled by the development efforts of eight Work Streams and informed by the needs of 24 Driver Projects and other key stakeholders. We present the GA4GH suite of secure, interoperable technical standards and policy frameworks and review the current status of standards, their relevance to key domains of research and clinical care, and future plans of GA4GH. Broad international participation in building, adopting, and deploying GA4GH standards and frameworks will catalyze an unprecedented effort in data sharing that will be critical to advancing genomic medicine and ensuring that all populations can access its benefits. ; B.P.C. acknowledges funding from Abigail Wexner Research Institute at Nationwide Children's Hospital; T.H. Nyrönen acknowledges funding from Academy of Finland grant #31996; A.M.-J., K.N., T.F.B., O.M.H., and Z.S. acknowledge funding from Australian Medical Research Future Fund; M.S. acknowledges funding from Biobank Japan; D. Bujold and S.J.M.J. acknowledge funding from Canada Foundation for Innovation; L.J.D. acknowledges funding from Canada Foundation for Innovation Cyber Infrastructure grant #34860; D. Bujold and G.B. acknowledge funding from CANARIE; L.J.D. acknowledges funding from CANARIE Research Data Management contract #RDM-090 (CHORD) and #RDM2-053 (ClinDIG); K.K.-L. acknowledges funding from CanSHARE; T.L.T. acknowledges funding from Chan Zuckerberg Initiative; T. Burdett acknowledges funding from Chan Zuckerberg Initiative grant #2017-171671; D. Bujold, G.B., and L.D.S. acknowledge funding from CIHR; L.J.D. acknowledges funding from CIHR grant #404896; M.J.S.B. acknowledges funding from CIHR grant #SBD-163124; M. Courtot and M. Linden acknowledge funding from CINECA project EU Horizon 2020 grant #825775; D. Bujold and G.B. acknowledge funding from Compute Canada; F.M.-G. acknowledges funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – NFDI 1/1 "GHGA – German Human Genome-Phenome Archive; R.M.H.-S. acknowledges funding from Duke-Margolis Center for Health Policy; S.B. and A.J.B. acknowledge funding from EJP-RD EU Horizon 2020 grant #825575; A. Niewielska, A.K., D.S., G.I.S., J.A.T., J.R., M.A.K., M. Baudis, M. Linden, S.B., S.S., T.H. Nyrönen, and T.M.K. acknowledge funding from ELIXIR; A. Niewielska acknowledges funding from EOSC-Life EU Horizon 2020 grant #824087; J.-P.H. acknowledges funding from ETH Domain Strategic Focal Area "Personalized Health and Related Technologies (PHRT)" grant #2017-201; F.M.-G. acknowledges funding from EUCANCan EU Horizon 2020 grant #825835; B.M.K., D. Bujold, G.B., L.D.S., M.J.S.B., N.S., S.E.W., and Y.J. acknowledge funding from Genome Canada; B.M.K., M.J.S.B., S.E.W., and Y.J. acknowledge funding from Genome Quebec; F.M.-G. acknowledges funding from German Human Genome-Phenome Archive; C. Voisin acknowledges funding from Google; A.J.B. acknowledges funding from Health Data Research UK Substantive Site Award; D.H. acknowledges funding from Howard Hughes Medical Institute; S.B. acknowledges funding from Instituto de Salud Carlos III; S.-S.K. and K.T. acknowledge funding from Japan Agency for Medical Research and Development (AMED); S. Ogishima acknowledges funding from Japan Agency for Medical Research and Development (AMED) grant #20kk0205014h0005; C.Y. and K. Kosaki acknowledge funding from Japan Agency for Medical Research and Development (AMED) grant #JP18kk0205012; GEM Japan acknowledges funding from Japan Agency for Medical Research and Development (AMED) grants #19kk0205014h0004, #20kk0205014h0005, #20kk0205013h0005, #20kk0205012h0005, #20km0405401h0003, and #19km0405001h0104; J.R. acknowledges funding from La Caixa Foundation under project #LCF/PR/GN13/50260009; R.R.F. acknowledges funding from Mayo Clinic Center for Individualized Medicine; Y.J. and S.E.W. acknowledge funding from Ministère de l'Économie et de l'Innovation du Québec for the Can-SHARE Connect Project; S.E.W. and S.O.M.D. acknowledge funding from Ministère de l'Économie et de l'Innovation du Québec for the Can-SHARE grant #141210; M.A.H., M.C.M.-T., J.O.J., H.E.P., and P.N.R. acknowledge funding from Monarch Initiative grant #R24OD011883 and Phenomics First NHGRI grant #1RM1HG010860; A.L.M. and E.B. acknowledge funding from MRC grant #MC_PC_19024; P.T. acknowledges funding from National University of Singapore and Agency for Science, Technology and Research; J.M.C. acknowledges funding from NHGRI; A.H.W. acknowledges funding from NHGRI awards K99HG010157, R00HG010157, and R35HG011949; A.M.-J., K.N., D.P.H., O.M.H., T.F.B., and Z.S. acknowledge funding from NHMRC grants #GNT1113531 and #GNT2000001; D.L.C. acknowledges funding from NHMRC Ideas grant #1188098; A.B.S. acknowledges funding from NHMRC Investigator Fellowship grant #APP177524; J.M.C. and L.D.S. acknowledge funding from NIH; A.A.P. acknowledges funding from NIH Anvil; A.V.S. acknowledges funding from NIH contract #HHSN268201800002I (TOPMed Informatics Research Center); S.U. acknowledges funding from NIH ENCODE grant #UM1HG009443; M.C.M.-T. and M.A.H. acknowledge funding from NIH grant #1U13CA221044; R.J.C. acknowledges funding from NIH grants #1U24HG010262 and #1U2COD023196; M.G. acknowledges funding from NIH grant #R00HG007940; J.B.A., S.L., P.G., E.B., H.L.R., and L.S. acknowledge funding from NIH grant #U24HG011025; K.P.E. acknowledges funding from NIH grant #U2C-RM-160010; J.A.E. acknowledges funding from NIH NCATS grant #U24TR002306; M.M. acknowledges funding from NIH NCI contract #HHSN261201400008c and ID/IQ Agreement #17X146 under contract #HHSN2612015000031 and #75N91019D00024; R.M.C.-D. acknowledges funding from NIH NCI grant #R01CA237118; M. Cline acknowledges funding from NIH NCI grant #U01CA242954; K.P.E. acknowledges funding from NIH NCI ITCR grant #1U24CA231877-01; O.L.G. acknowledges funding from NIH NCI ITCR grant #U24CA237719; R.L.G. acknowledges funding from NIH NCI task order #17X147F10 under contract #HHSN261200800001E; A.F.R. acknowledges funding from NIH NHGRI grant #RM1HG010461; N.M. and L.J.Z. acknowledge funding from NIH NHGRI grant #U24HG006941; R.R.F., T.H. Nelson, L.J.B., and H.L.R. acknowledge funding from NIH NHGRI grant #U41HG006834; B.J.W. acknowledges funding from NIH NHGRI grant #UM1HG009443A; M. Cline acknowledges funding from NIH NHLBI BioData Catalyst Fellowship grant #5118777; M.M. acknowledges funding from NIH NHLBI BioData Catalyst Program grant #1OT3HL142478-01; N.C.S. acknowledges funding from NIH NIGMS grant #R35-GM128636; M.C.M.-T., M.A.H., P.N.R., and R.R.F. acknowledge funding from NIH NLM contract #75N97019P00280; E.B. and A.L.M. acknowledge funding from NIHR; R.G. acknowledges funding from Project Ris3CAT VEIS; S.B. acknowledges funding from RD-Connect, Seventh Framework Program grant #305444; J.K. acknowledges funding from Robertson Foundation; S.B. and A.J.B. acknowledge funding from Solve-RD, EU Horizon 2020 grant #779257; T.S. and S. Oesterle acknowledge funding from Swiss Institute of Bioinformatics (SIB) and Swiss Personalized Health Network (SPHN), supported by the Swiss State Secretariat for Education, Research and Innovation SERI; S.J.M.J. acknowledges funding from Terry Fox Research Institute; A.E.H., M.P.B., M. Cupak, M.F., and J.F. acknowledge funding from the Digital Technology Supercluster; D.F.V. acknowledges funding from the Australian Medical Research Future Fund, as part of the Genomics Health Futures Mission grant #76749; M. Baudis acknowledges funding from the BioMedIT Network project of Swiss Institute of Bioinformatics (SIB) and Swiss Personalized Health Network (SPHN); B.M.K. acknowledges funding from the Canada Research Chair in Law and Medicine and CIHR grant #SBD-163124; D.S., G.I.S., M.A.K., S.B., S.S., and T.H. Nyrönen acknowledge funding from the EU Horizon 2020 Beyond 1 Million Genomes (B1MG) Project grant #951724; P.F., A.D.Y., F.C., H.S., I.U.L., D. Gupta, M. Courtot, S.E.H., T. Burdett, T.M.K., and S.F. acknowledge funding from the European Molecular Biology Laboratory; Y.J. and S.E.W. acknowledge funding from the Government of Canada; P.G. acknowledges funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-206); J.Z. acknowledges funding from the Government of Ontario; C.K.Y. acknowledges funding from the Government of Ontario, Canada Foundation for Innovation; C. Viner and M.M.H. acknowledge funding from the Natural Sciences and Engineering Research Council of Canada (grant #RGPIN-2015-03948 to M.M.H. and Alexander Graham Bell Canada Graduate Scholarship to C.V.); K.K.-L. acknowledges funding from the Program for Integrated Database of Clinical and Genomic Information; J.K. acknowledges funding from the Robertson Foundation; D.F.V. acknowledges funding from the Victorian State Government through the Operational Infrastructure Support (OIS) Program; A.M.L., R.N., and H.V.F. acknowledge funding from Wellcome (collaborative award); F.C., H.S., P.F., and S.E.H. acknowledge funding from Wellcome Trust grant #108749/Z/15/Z; A.D.Y., H.S., I.U.L., M. Courtot, H.E.P., P.F., and T.M.K. acknowledge funding from Wellcome Trust grant #201535/Z/16/Z; A.M., J.K.B., R.J.M., R.M.D., and T.M.K. acknowledge funding from Wellcome Trust grant #206194; E.B., P.F., P.G., and S.F. acknowledge funding from Wellcome Trust grant #220544/Z/20/Z; A. Hamosh acknowledges funding from NIH NHGRI grant U41HG006627 and U54HG006542; J.S.H. acknowledges funding from National Taiwan University #91F701-45C and #109T098-02; the work of K.W.R. was supported by the Intramural Research Program of the National Library of Medicine, NIH. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. H.V.F. acknowledges funding from Wellcome Grant 200990/A/16/Z 'Designing, developing and delivering integrated foundations for genomic medicine'. ; Peer reviewed
The article is an extended and revised version of the report published in April 2020 in Russian: E. Puchkov, N. Knyaginina, I. Novoselov, Sz. Jankiewicz, Covid-19 and GIA-2020: strategies for conducting final exams in foreign and Russian universities // Modern Education Analytics. Express edition No. 4. April 20, 2020. URL: https://ioe.hse.ru/mirror/pubs/share/359132748 (15.06.2020). ; COVID-19 pandemic has changed the functioning of all levels of education systems. Schools and universities had to quickly adapt and change their procedures according to conditions created by the epidemic. Long perceived as additional and backup solutions, different distance learning technologies, particularly internet-based, became the main solution for the continuation of education on all levels. Several issues have stood out particularly with this seismic change – one of those is the issue of final examinations in universities. This issue is especially crucial in Russia, where the successful passing of a state final examination, which combines majority of the topics from the study program, is a prerequisite for graduation. This paper aims to analyze and present different strategies which were used for final university examinations in different countries and universities of the world and compare it with the Russian practices. ; Evgenii Puchkov: epuchkov@hse.ru ; Nadezhda Knyaginina: nknyaginina@hse.ru ; Ivan Novoselov: inovoselov@hse.ru ; Szymon Jankiewicz: syankevich@hse.ru ; Evgenii Puchkov – analityk Laboratorium Prawa Edukacji Instytutu Edukacji Wyższej Szkoły Ekonomicznej w Moskwie (Rosja), doktorant w Instytucie Edukacji Wyższej Szkoły Ekonomicznej. Jego zainteresowania badawcze obejmują zagadnienia relacji pomiędzy polityką edukacyjną a prawodawstwem w zakresie zrównoważonego rozwoju, umiędzynarodowienie edukacji oraz badania porównawcze prawodawstwa edukacyjnego. ; Evgenii Puchkov – Analyst of the Education Law Laboratory of the Institute of Education, Higher School of Economics, Moscow, Russia, Ph.D. student in the Institute of Education of Higher School of Economics. His research interests include issues of relationship between educational policy and legislation with sustainable development, internationalization of education and comparative study of educational legislation. ; Nadezhda Knyaginina – pracownik badawczy Laboratorium Prawa Edukacji Instytutu Edukacji w Wyższej Szkole Ekonomicznej w Moskwie (Rosja). Posiada tytuł specjalisty w dziedzinie prawa na Wydziale Prawa Wyższej Szkoły Ekonomicznej. Jej zainteresowania badawcze obejmują zagadnienia prawa edukacyjnego, praw językowych, polityki językowej w działalności edukacyjnej, federalizmu w edukacji, jakości edukacji, standardów edukacyjnych i regulacji zapewniania jakości edukacji. ; Nadezhda Knyaginina – Research Fellow of the Education Law Laboratory of the Institute of Education, Higher School of Economics, Moscowholding Specialist Degree in Law from Faculty of Law of Higher School of Economics. Her research interests include issues of educational law, language rights, language policy in educational activities, federalism in education, quality of education, education standards and regulation of quality assurance of education. ; Ivan Novoselov – asystent badawczy Laboratorium Prawa Edukacji Instytutu Edukacji w Wyższej Szkole Ekonomicznej w Moskwie (Rosja). Posiada tytuł magistra prawa finansowego, podatkowego i celnego, uzyskany na Wydziale Prawa Wyższej Szkoły Ekonomicznej. Jego zainteresowania badawcze obejmują zagadnienia z zakresu prawa edukacyjnego, finansowego i budżetowego oraz studiów porównawczych z zakresu prawa edukacyjnego i finansowego. ; Ivan Novoselov – Research Assistant of the Education Law Laboratory of the Institute of Education, Higher School of Economics, Moscow, Russiaholding Master Degree in Financial, Tax and Customs Law from Faculty of Law of Higher School of Economics. His research interests include issues of educational law, financial and budgetary law and comparative studies of educational and financial legislation. ; Szymon Jankiewicz – doktor, prodziekan Wydziału Prawa, kierownik Laboratorium Prawa Edukacji Instytutu Edukacji w Wyższej Szkole Ekonomicznej w Moskwie (Rosja), doktor (kandydat nauk) prawa finansowego Instytutu Prawodawstwa i Prawa Porównawczego przy Rządzie Federacji Rosyjskiej oraz magister prawa finansowego, podatkowego i celnego na Wydziale Prawa Wyższej Szkoły Ekonomicznej. Jego zainteresowania badawcze obejmują zagadnienia prawa edukacyjnego, prawa finansowego, regulacji finansowych i budżetowych działalności edukacyjnej i instytucji edukacyjnych oraz regulacji zapewniania jakości kształcenia. ; Szymon Jankiewicz – Ph.D. Deputy Dean of the Faculty of Law, Head of the Education Law Laboratory of the Institute of Education, Higher School of Economics, Moscow, Russia with Ph.D. (Candidate of Sciences) in Financial Law from The Institute of Legislation and Comparative Law under the Government of the Russian Federation as well as Master Degree in Financial, Tax and Customs Law from Faculty of Law of Higher School of Economics. His research interests include issues of educational law, financial law, financial and budgetary regulation of educational activities and educational institutions and regulation of quality assurance of education. ; Evgenii Puchkov - Higher School of Economics, Moscow, Russia ; Nadezhda Knyaginina - Higher School of Economics, Moscow, Russia ; Ivan Novoselov - Higher School of Economics, Moscow, Russia ; Szymon Jankiewicz - Higher School of Economics, Moscow, Russia ; 7News. Coronavirus in Australia: Several universities won't record students' failed units during crisis, https://7news.com.au/lifestyle/health-wellbeing/coronavirus-in-australia-several-universities-wont-record-students-failed-units-during-crisis-c-949545. ; Bristol University. Assessment Options When Teaching Online. https://www.bristol.ac.uk/digital-education/guides/coronavirus/assessment/. ; Catholic University of Leuven. Exams 2020 General Guidelines https://admin.kuleuven.be/td/examens2020/en/general-guidelines. ; Examus, https://ru.examus.net. ; Federal Law No. 273-FZ of December 29, 2012 "On Education in the Russian Federation". ; Free University of Brussels. Back to Campus, https://www.vub.be/en/backtocampus#home. ; Harvard Crimson, Harvard Courses Turn to Monitored Exams, Open-Book Assessments, and Faith in Students As Classes Move Online, https://www.thecrimson.com/article/2020/3/27/harvard-coronavirus-online-exams-academic-integrity/. ; Harvard Crimson. Harvard Law School Shifts to Mandatory Credit-Fail Grading System. https://www.thecrimson.com/article/2020/3/21/harvard-coronavirus-law-school-credit-fail/. ; HSE University. Proctoring, https://elearning.hse.ru/proctoring2/. ; Interfax. Moscow State University will hold State Exams and Theses Defense Online, https://www.interfax.ru/russia/703559. ; Interfax. State Exams Were Cancelled in Several Ural Federal University Institutes, https://www.interfax-russia. ru/ural/main/gosekzameny-otmenili-v-ryade-institutov-urfu. ; ITMO University. Proctoring: How to Pass Exams Online, https://de.ifmo.ru/?node=news&id=2161. ; Izvestia. Ministry of Science and Higher Education Affirms the Right of Universities to Cancel State Exams, https://iz.ru/1000499/2020–04-16/v-minobrnauki-zaiavili-o-prave-vuzov-rossii-otkazatsia-ot-gosekzamenov. ; Kommersant. «Hands of the Student Should be Visible on the Screen»: Kommersant Learned How Exam Session Will be Handled during Quarantine, https://www.kommersant.ru/doc/4314144. ; Law.com. Remaining 'T-14' Law Schools Yield to Mandatory Pass/Fail Pressure https://www.law.com/2020/03/31/with-passfail-now-the-norm-outlier-law-schools-face-student-backlash/?slreturn=20200525050454. ; Law.com. With Pass/Fail Now the Norm, Outlier Law Schools Face Student Backlash, https://www.law.com/2020/03/31/with-passfail-now-the-norm-outlier-law-schools-face-student-backlash/. ; Mare. How are we going to test (and do we let Big Brother watch)? https://www.mareonline.nl/en/background/how-are-we-going-to-test-and-do-we-let-big-brother-watch/. ; Nesavisimaya Gazeta, Students have rallied against proctoring, citing privacy concerns, https://www.ng.ru/content/articles/681938/. ; Order of Ministry of Higher Education and Science of Russian Federation № 648 of 8.05.2020 "On the activities of organizations subordinated to Ministry of Higher Education and Science of Russian Federation in the context of preventing the spread of a novel coronavirus infection (COVID-19) in the Russian Federation". ; Orgeon State University Exam Proctoring, https://ecampus.oregonstate.edu/services/proctoring. ; Oxford University. Open-Book Exams, https://www.ox.ac.uk/students/academic/exams/open-book?wssl=1. ; Pervoe Studenheskoye Agesntvo. 700 students of HSE couldn't pass online exams due to hacker attack, https://pervoe.online/news/student-v-vuze/8642-ddos_ataka_hse/. ; Procedures of Conducting Final State Attestation in Bachelor, Spetsialist and Master Higher Education Programs (adopted by Order of Ministry of Higher Education and Science №636 of 29 June 2015). ; ProctorEdu Technology, https://proctoredu.ru. ; ProctorFree Solutions for Education, https://proctorfree.com/. ; ProctorU Services, https://www.proctoru.com/services/ ; QS. Italian Institutions Reveal Their Coronavirus Insights: An Interview Series, https://www.qs.com/italian-institutions-reveal-their-coronavirus-insights-an-interview-series. ; TASS. Financial University Cancelled State Exams Due to Coronavirus, https://tass.ru/obschestvo/8244377. ; The Guardian. Medical students take final exams online for first time, despite student concern, https://www.theguardian.com/education/2020/mar/22/coronavirus-forces-medical-students-sit-final-exams-online. ; The Guardian. UK students' union calls on universities to cancel summer exams, https://www.theguardian.com/education/2020/mar/31/uk-students-union-calls-on-universities-to-cancel-summer-exams. ; The New Paper. NUS students allegedly abuse Covid-19 measures to cheat on exam, https://www.tnp.sg/news/singapore/nus-students-allegedly-abuse-covid-19-measures-cheat-exam. ; The New York Times. With Coronavirus Disrupting College, Should Every Student Pass? https://www.nytimes.com/2020/03/28/us/coronavirus-college-pass-fail.html. ; The New York Times. Keeping Online Testing Honest? Or an Orwellian Overreach? https://www.nytimes.com/2020/05/10/us/online-testing-cheating-universities-coronavirus.html. ; The Verge. Exam Anxiety: How Remote Test-Proctoring Is Creeping Students Out, https://www.theverge.com/2020/4/29/21232777/examity-remote-test-proctoring-online-class-education. ; Times Higher Education. Asian universities face online assessment hurdles in virus crisis, https://www.timeshighereducation.com/news/asian-universities-face-online-assessment-hurdles-virus-crisis. ; University of Alberta. COVID-19 (novel Coronavirus) Information, https://www.ualberta.ca/covid-19/index.html. ; University of Bologna, Online lessons and exams, https://www.unibo.it/en/services-and-opportunities/online-services/online-services-for-students-1/lessons-and-exams-online. ; University of Houston Proctoring Services, https://uh.edu/online/students/proctoring-students.php. ; University of Stirling. COVID-19 (coronavirus) FAQs for students on assessment and exams, https://www.stir.ac.uk/coronavirus/covid-19-coronavirus-faqs-for-students-on-assessment-and-exams/. ; University of Warwick. Examinations, https://warwick.ac.uk/services/academicoffice/examinations/. ; 25 ; 4 ; 257 ; 271
ABSTRACT The main objectives of this study is to determine the interactions between deposit interest rates, foreign exchange rates and stock market index (LQ45) in Indonesia pre and post crisis 2008. The data period before the crisis is October 2000 until November 2008. The data period after the crisis is December 2008 until December 2015. Descriptive quantitative analysis is used in this research. Descriptive analysis method is performed by using analytical table and graphic. Quantitative analysis method is performed by making a regression equation econometric model with time series method to describe the presence or absence of the influence of the independent variable towards the dependant variable. The result showed that during the pre crisis 2008, unidirectional causality existed from Deposit Interest Rates towards Foreign Exchange Rates, Stock Market Index (LQ45) towards Deposit Interest Rates, Deposit Interest Rates towards Stock Market Index(LQ45), and Stock Market Index (LQ45) towards Foreign Exchange Rates. The result post crisis 2008 showed that unidirectional causality existed from Foreign Exchange Rates towards Deposit Interest Rates, Deposit Interest Rates towards Foreign Exchange Rates, and Stock Market Index (LQ45) towards Foreign Exchange Rates. It is found that the direction of causality between the three variables tends to demonstrate a hit-and-run behavior and changes according to the lag selection. This implies that great caution should be taken when interpreting granger causality result. Keywords: Deposit Interest Rates, Foreign Exchange Rates, Stock Market Index, LQ45, Granger Causality and Subprime MortgageBIBLIOGRAPHY (2008, September 15). Retrieved September 15, 2016, from CNBC: http://www.cnbc.com/id/26708143(2016, November 1). Retrieved from Investing: https://www.investing.com/indices/jakarta-lq45(2016, September 21). Retrieved September 12, 2016, from Consumer Financial Protection Bureau: http://www.consumerfinance.gov/askcfpb/110/what-is-a-subprime-mortgage.htmlInternational Monetary Fund (IMF)'s International Financial Statistics. (2016, October 22). Retrieved from http://data.imf.org/regular.aspx?key=60998108(2018, October 8). Retrieved October 8, 2018, from www.idx.co.id: http://www.idx.co.id/media/1482/lq45-index-methodology-by-idx.pdf(2018). Retrieved July 03, 2018, from Oxford Dictionaries: https://en.oxforddictionaries.com/definition/interest_rate(2018). Retrieved July 3, 2018, from Cambridge Dictionary: https://dictionary.cambridge.org/dictionary/english/interest-rate(2018). Retrieved July 04, 2018, from Cambridge Dictionary: https://dictionary.cambridge.org/dictionary/english/certificate-of-depositInternational Monetary Fund. (2018). Retrieved July 3, 2018, from http://data.imf.org/regular.aspx?key=61545855Ahmed, M., Rehman, R., & Raoof, A. (2010). Do interest rate, exchange rate effect stock returns? A Pakistani perspective. International Research Journal of Finance and Economics(50), 146-150.Ajayi, R., & Mougoue, M. (1996). On the dynamic relation between stock prices and exchange rates. Journal of Financial Research, 19, 193-207.Alam, M. M., & Uddin, M. G. (2009). Relationship between interest rate and stock price: Empirical evidence from developed and developing countries. International Journal of Business and Management Vol.4, No. 3, 43-51.Alam, S., Butt, M. S., & Iqbal, A. (2001). The Long-run Relationship between Real Exchange Rate and Real Interest Rate in Asian Countries: An Application of Panel Cointegration. The Pakistan Development Review, 577-602.Allaro, H. B., Kassa, B., & Hundie, B. (2011). A time series analysis of structural break time in themacroeconomic variables in Ethiopia. African Journal of Agricultural Research Vol. 6(2), 392-400.Amadeo, K. (2016, July 26). Retrieved from The Balance: https://www.thebalance.com/what-caused-2008-global-financial-crisis-3306176CEO, D. (2016, November 19). Retrieved from Tribuneindia: http://www.tribuneindia.com/news/business/fixed-deposit-best-option-for-risk-averse-investors/230726.htmlCho, D., & West, K. (2001). Interest Rates and Exchange Rates in the Korean, Philippine, and Thai Exchange Rate Crisis. NBEP, Conference on Management of Currency Crisis. Monterey, California.Chow, H. K., & Kim, Y. (2004). The Empirical Relationship Between Exchange Rates and Interest Rates in Post-Crisis Asia. School of Economics and Social Sciences, Singapore Management University.Commission, T. F. (2011). The Financial Crisis Inquiry Report. Subprime Lending, 70.Commission, T. F. (2011). The Financial Crisis Inquiry Report, Final Report Of The National Commission On The Causes Of The Financial And Economic Crisis In The United States. Washington D.C: Official Government Edition.Dash, P. (2001). The Relationship between Interest Rate and Exchange Rate in India. Indian Economic Journal.Eichenbaum, M., & Evans, C. L. (1995). Some Empirical Evidence on the Effects of Shocks to Monetary Policy on Exchange Rates. The Quarterly Journal of Economics, Vol. 110, No. 4, 975-1009.Elton, E. J., Gruber, M. J., Brown, S. J., & Goetzmann, W. N. (2003). Modern Portfolio Theory and Investment Analysis. New York: John Wiley & Sons, Inc.Fama, E. F. (1991). Efficient Capital Market : II. The Journal Of Finance. Vol 46 No.5 December 1991, 1575-1617.Fang, W. (2000). Stock market process and expected depreciation over the Asian financial crisis. Applied Economics, 2001, 33, 905-912.Furman, J., & Stiglitz, J. (1998). Economic Crisis: Evidence and Insights from East Asia. Brookings Papers on Economic Activity, 1-135.Goldfajn, I., & Gupta, P. (1999). Does Monetary Policy Stabilize the Exchange Rate Following a Currency Crisis? Working Paper of the International Monetary Fund.Granger, C. W. (1986). Developments in the Study of Cointegrated Economic Variables. Oxford Bulletin of Economics and Statistics, 213-228.Granger, C. W., & Newbold, P. (1974). Spurious Regressions In Econometrics. Journal Of Econometrics 2, 111-120.Granger, C., Huang, B. N., & Yang, C. (2000). A Bivariate Causality between Stock Prices and Exchange Rates: Evidence from Recent Asian Flu. The Quarterly Review of Economics and Finance 40, 337-354.Grant, A. (1988). Handbook of Money and Capital Market. Connecticut: Quorum Books, Greendwood Press, Inc.Gujarati, D. N. (2003). Basic Econometrics Fourth Edition. New York: McGraw-Hill.Gümüş, İ. (2003). Effects of the Interest Rate Defense on Exchange Rates During the 1994 Crisis in Turkey. Research Department Working Paper No.14 The Central Bank Of The Republic Of Turkey.Hidayat, T. (2017, February 14). Teguh Hidayat & Partners. Retrieved from http://www.thpartner.com/2016/02/what-is-lq45.htmlHyde, S. (2007). The response of Industry stock returns to market, exchange rate and interest rate risks. Managerial Finance, 693-709.Kasman, S. (2003). The relationship between exchange rate and stock prices: a causality analysis.Kayhan, S., Bayat, T., & Ugur, A. (2013). Interest Rates and Exchange Rate Relationship in BRIC-T Countries. Ege Academic Review, 227-236.Kearney, C. (1998). The causes of volatility in a small, internationally integrated stock market: Ireland, July 1975-June 1994. Journal of Financial Research, 21(1), 85-104.Keynes, J. M. (1936). The General Theory of Employment, Interest and Money. United Kingdom: Palgrave Macmillan.Koutoulas, G., & Kryzanowski, L. (1996). Macrofactor conditional volatility, time-varying risk premia and stock return behavior. Financial Review, 31, 169-195.Lean, H.-H., Halim, M., & Wong, W.-K. (2003). Bivariate Causality Between Exchange Rate and Stock Price On Major Asian Countries. Department Of Economics National University Of Singapore.Levi, M. D. (1996). International Finance The Markets and Financial Management of Multinational Business 3rd Edition. New York: McGraw-Hill, Inc.Lo, A. W. (2016). What Is An Index? The Journal Of Portfolio Management Volume 42 Number 2, 2.M, K., & S, Y. A. (2013). Macroeconomic forces and stock prices: Evidence from the Bangladesh Stock Market. Bangladesh: Dhaka.Madura, J. (2012). Financial Institutions & Markets. Florence: Cengage Learning, Inc .Mankiw, N. G. (2009). Macroeconomics Seventh Edition. New York: Worth Publishers.Markowitz, H. (1952). Portfolio Selection. The Journal of Finance, Vol. 7, No. 1., 77-91.Mbulawa, S. (2015). Stock Market Performance, Interest Rate and Exchange Rate Interactions in Zimbabwe: A Cointegration Approach. International Journal of Economics, Finance and Management VOL. 4, NO. 2, 77-88.Mishkin, F. (2011). The Economics of Money Banking and Financial Market. Fourth Canadian Edition. Toronto: Pearson Canada.Mishkin, F. S. (2010). The Economics of Money, Banking, and Financial Markets Buku 2. Jakarta: Salemba Empat.Mukherjee, T., & Naka, A. (1995). Dynamic relations between macroeconomic variables and the Japanese stock market: an application of a vector error correction model. Journal of Financial Research, 18, 223-237.Pan, Ming-Shiun, Fok, R. C.-W., & Liu, A. Y. (2000). Dynamic Linkages Between Exchange Rates and Stock Prices: Evidence from Pacific Rim Countries. Working Paper, Financial Management Association Annual Meeting.Pettinger, T. (2017, January 20). Retrieved from Economicshelp: http://www.economicshelp.org/macroeconomics/exchangerate/factors-influencing/Purna, I., Hamidi, & Prima. (2009, May 26). Perekonomian Indonesia Tahun 2008 Tengah Krisis Keuangan Global. Retrieved September 23, 2016, from Kementerian Sekretariat Negara Republik Indonesia: http://www.setneg.go.id/index.php?option=com_content&task=view&id=3698Ramasamy, B., & Young, M. (2001). The Causality between Stock Return and Exchange Rate. Research Paper Series University of Notthingham Malaysia.Sánchez, M. (2005). The Link Between Interest Rates And Exchange Rates. Do Contractionary Depreciations Make A Difference? European Central Bank Working Paper Series No.548 / November2005, 6.Saragih, F. D., & Nugroho, B. Y. (2014). Dasar - Dasar Keuangan Internasional. Jakarta: PT.Raja Grafindo Persada.Sargent, T. J., & Wallace, N. (1981). Some Unpleasant Monetarist Arithmetic. Federal Reserve Bank of Minneapolis Quarterly Review, No.5, Fall, 1-17.Saunders, A., & Cornett, M. M. (2012). Financial Markets And Institutions Fifth Edition. In A. Saunders, & M. M. Cornett, Financial Markets And Institutions Fifth Edition (p. 344). New York: McGraw-Hill/Irwin.Sharpe, W. F. (1991). The Arithmetic of Active Management. Financial Analysts Journal, 7-9.Tambunan, T. T. (2010). Modern Economy. The Indonesian Experience with Two Big Economic Crises, 156-167.Tandelilin, E. (2010). Portfolio dan Investasi. Yogyakarta: Kanisius.
